SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of May, 2020
Commission File Number 1565025
AMBEV S.A.
(Exact name of registrant as specified in its charter)
AMBEV S.A.
(Translation of Registrant's name into English)
Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____
Ambev S.A.
Interim consolidated
financial statements at
March 31, 2020
and report on review
Report on review of interim
consolidated financial statements
To the Board of Directors and Stockholders
Ambev S.A.
Introduction
We have reviewed the accompanying interim balance sheet of Ambev S.A. and its subsidiaries as at March 31, 2020 and the related consolidated statements of income, comprehensive income, changes in equity and cash flows for the quarter then ended, and a summary of significant accounting policies and other explanatory notes.
Management is responsible for the preparation and fair presentation of these interim consolidated financial statements in accordance with the accounting standard CPC 21, Interim Financial Reporting, of the Brazilian Accounting Pronouncements Committee (CPC), and International Accounting Standard (IAS) 34 - Interim Financial Reporting, of the International Accounting Standards Board (IASB). Our responsibility is to express a conclusion on these interim financial statements based on our review.
Scope of review
We conducted our review in accordance with Brazilian and International Standards on Reviews of Interim Financial Information (NBC TR 2410 - Review of Interim Financial Information Performed by the Independent Auditor of the Entity, and ISRE 2410 - Review of Interim Financial Information Performed by the Independent Auditor of the Entity, respectively). A review of interim information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Brazilian and International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim consolidated financial statements referred to above do not present fairly, in all material respects, the financial position of Ambev S.A. and its subsidiaries as at March 31, 2020, and the consolidated financial performance and cash flows for the quarter then ended, in accordance with CPC 21 and IAS 34.
São Paulo, May 15, 2020
PricewaterhouseCoopers
Auditores Independentes
CRC 2SP000160/O-5
Alessandro Marchesino de Oliveira
CRC 1SP265450/O-8
PricewaterhouseCoopers, Av. Francisco Matarazzo 1400, Torre Torino, São Paulo, SP, Brasil, 05001-903, Caixa Postal 60054, T: +55 (11) 3674 2000, www.pwc.com.br
AMBEV S.A.
Interim Consolidated Balance Sheets
All amounts in thousand of Brazilian Reais unless otherwise stated
Assets
|
Note
|
03/31/2020
|
12/31/2019
|
|
|
|
|
Cash and cash equivalents
|
5
|
13,204,472
|
11,900,666
|
Investment securities
|
6
|
44,823
|
14,558
|
Derivative financial instruments
|
21
|
371,319
|
172,147
|
Trade receivable
|
|
3,394,298
|
4,495,525
|
Inventories
|
7
|
7,752,656
|
5,978,557
|
Income tax and social contributions recoverable
|
|
3,112,628
|
1,831,401
|
Other recoverable taxes
|
|
2,153,780
|
2,242,726
|
Other assets
|
|
1,052,380
|
985,557
|
Current assets
|
|
31,086,356
|
27,621,137
|
|
|
|
|
|
|
|
|
Investment securities
|
6
|
200,856
|
163,570
|
Derivative financial instruments
|
21
|
430
|
1,221
|
Income tax and social contributions recoverable
|
|
3,054,334
|
4,331,901
|
Other recoverable taxes
|
|
730,764
|
671,084
|
Deferred tax assets
|
8
|
4,048,189
|
2,950,109
|
Other assets
|
|
1,899,147
|
1,751,699
|
Employee benefits
|
|
71,164
|
56,228
|
Investments in joint ventures
|
|
339,602
|
303,423
|
Property, plant and equipment
|
9
|
25,063,436
|
22,576,299
|
Intangible
|
|
7,842,459
|
6,306,364
|
Goodwill
|
10
|
39,350,824
|
35,009,909
|
Non-current assets
|
|
82,601,205
|
74,121,807
|
|
|
|
|
Total assets
|
|
113,687,561
|
101,742,944
|
The accompanying notes are an integral part of these interim consolidated financial statements.
1
AMBEV
S.A.
Interim Consolidated Balance
Sheets (continued)
All amounts in
thousand of Brazilian Reais unless otherwise stated
Equity and
liabilities
|
Note
|
03/31/2020
|
12/31/2019
|
|
|
|
|
Trade payables
|
|
16,321,089
|
15,069,575
|
Derivative financial instruments
|
21
|
1,172,353
|
355,314
|
Interest-bearing loans and borrowings
|
11
|
780,090
|
653,149
|
Bank overdrafts
|
5
|
-
|
24
|
Wages and salaries
|
|
976,342
|
833,025
|
Dividends and interest on shareholders’
equity payable
|
|
1,072,858
|
956,560
|
Income tax and social contribution
payable
|
|
1,309,991
|
1,394,178
|
Taxes and contributions payable
|
|
1,759,831
|
4,108,521
|
Other liabilities
|
|
1,705,544
|
1,530,654
|
Provisions
|
12
|
120,025
|
110,033
|
Current liabilities
|
|
25,218,123
|
25,011,033
|
|
|
|
|
Trade payables
|
|
271,003
|
309,567
|
Derivative financial instruments
|
21
|
6,565
|
56
|
Interest-bearing loans and borrowings
|
11
|
2,693,360
|
2,409,655
|
Deferred tax liabilities
|
8
|
2,861,787
|
2,371,098
|
Income tax and social contribution
payable
|
|
2,212,175
|
2,219,551
|
Taxes and contributions payable
|
|
695,325
|
645,155
|
Put option granted on subsidiary and other
liabilities
|
|
4,178,288
|
3,145,393
|
Provisions
|
12
|
367,135
|
370,972
|
Employee benefits
|
|
3,074,730
|
2,704,459
|
Non-current liabilities
|
|
16,360,368
|
14,175,906
|
|
|
|
|
Total liabilities
|
|
41,578,491
|
39,186,939
|
|
|
|
|
Equity
|
13
|
|
|
Issued capital
|
|
57,899,073
|
57,866,759
|
Reserves
|
|
75,701,795
|
75,685,730
|
Carrying value adjustments
|
|
(64,632,941)
|
(72,274,464)
|
Retained earnings / (losses)
|
|
1,391,979
|
-
|
Equity attributable to equity holders of
Ambev
|
|
70,359,906
|
61,278,025
|
Non-controlling interests
|
|
1,749,164
|
1,277,980
|
Total Equity
|
|
72,109,070
|
62,556,005
|
|
|
|
|
Total equity and liabilities
|
|
113,687,561
|
101,742,944
|
|
|
|
|
The
accompanying notes are an integral part of these interim consolidated financial
statements.
2
AMBEV
S.A.
Interim Consolidated Income
Statements
For the period ended
March 31
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
Note
|
2020
|
2019
|
|
|
|
|
Net sales
|
15
|
12,602,597
|
12,640,126
|
Cost of sales
|
|
(5,643,189)
|
(5,107,701)
|
Gross profit
|
|
6,959,408
|
7,532,425
|
|
|
|
|
Distribution expenses
|
|
(1,851,313)
|
(1,626,722)
|
Sales and marketing expenses
|
|
(1,555,539)
|
(1,401,281)
|
Administrative expenses
|
|
(665,346)
|
(661,522)
|
Other operating income/(expenses),
net
|
16
|
171,269
|
231,253
|
Restructuring
|
17
|
(13,880)
|
(18,211)
|
Effect of application of IAS 29
(hyperinflation)
|
17
|
-
|
(209)
|
COVID-19 impacts
|
17
|
(10,195)
|
-
|
Income from operations
|
|
3,034,404
|
4,055,733
|
|
|
|
|
Finance expenses
|
18
|
(1,782,643)
|
(959,761)
|
Finance income
|
18
|
245,776
|
287,693
|
Net finance result
|
|
(1,536,867)
|
(672,068)
|
|
|
|
|
Share of result of joint
ventures
|
|
(6,617)
|
(2,136)
|
Income before income tax
|
|
1,490,920
|
3,381,529
|
|
|
|
|
Income tax expense
|
19
|
(279,668)
|
(632,461)
|
Net income
|
|
1,211,252
|
2,749,068
|
|
|
|
|
Attributable to:
|
|
|
|
Equity holders of Ambev
|
|
1,091,784
|
2,661,850
|
Non-controlling interests
|
|
119,468
|
87,218
|
|
|
|
|
Basic earnings per share – common -
R$
|
|
0.0694
|
0.1693
|
Diluted earnings per share – common -
R$
|
|
0.0688
|
0.1678
|
The
accompanying notes are an integral part of these interim consolidated financial
statements.
3
AMBEV
S.A.
Interim Consolidated Statements
of Comprehensive Income
For the period ended
March 31
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
2020
|
2019
|
|
|
|
Net income
|
1,211,252
|
2,749,068
|
|
|
|
Items that will not be reclassified to
profit or loss:
|
|
|
Recognition of actuarial
gains/(losses)
|
(4,754)
|
3,407
|
|
|
|
Items that may be reclassified
subsequently to profit or loss:
|
|
|
Exchange differences on translation of
foreign operations (gains/(losses)
|
|
|
Investment hedge
- put option granted on subsidiary
|
(574,974)
|
(5,681)
|
Gains/losses on
translation of other foreign operations
|
8,054,805
|
(192,810)
|
Gains/losses on
translation of foreign operations
|
7,479,831
|
(198,491)
|
|
|
|
Cash flow hedge -
gains/(losses)
|
|
|
Recognized in
Equity (Hedge reserve)
|
898,514
|
422,713
|
Removed from
Equity (Hedge reserve) and included in profit or loss
|
(355,682)
|
(437,035)
|
Total cash flow
hedge
|
542,832
|
(14,322)
|
|
|
|
Other comprehensive (loss)/income
|
8,017,909
|
(209,406)
|
|
|
|
Total comprehensive income
|
9,229,161
|
2,539,662
|
|
|
|
Attributable to:
|
|
|
Equity holders of Ambev
|
8,734,835
|
2,451,219
|
Non-controlling interest
|
494,326
|
88,443
|
The accompanying notes are an
integral part of these interim consolidated financial statements. The
consolidated statements of comprehensive income are presented net of income tax.
The income tax effects of these items are disclosed in Note 8 - Deferred income tax
and social contribution.
4
AMBEV
S.A.
Interim Consolidated Statements
of Changes in Equity
For the period ended
March 31
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
Attributable to equity holders of Ambev
|
|
|
|
|
Capital
|
Capital reserves
|
Net income reserves
|
Retained earnings
|
Carrying value
adjustments
|
Total
|
|
Non-controlling
interests
|
Total
equity
|
At December 31, 2018
|
57,710,202
|
54,781,194
|
15,341,367
|
-
|
(71,584,756)
|
56,248,007
|
|
1,206,801
|
57,454,808
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
-
|
-
|
-
|
2,661,850
|
-
|
2,661,850
|
|
87,218
|
2,749,068
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
-
|
|
|
|
|
|
|
Gains/(losses) on translation of
foreign operations
|
-
|
-
|
-
|
-
|
(198,902)
|
(198,902)
|
|
411
|
(198,491)
|
Cash flow hedges
|
-
|
-
|
-
|
-
|
(14,824)
|
(14,824)
|
|
502
|
(14,322)
|
Actuarial gains/(losses)
|
-
|
-
|
-
|
-
|
3,095
|
3,095
|
|
312
|
3,407
|
Total comprehensive income
|
-
|
-
|
-
|
2,661,850
|
(210,631)
|
2,451,219
|
|
88,443
|
2,539,662
|
Capital increase (Note 13)
|
88,642
|
(86,118)
|
-
|
-
|
-
|
2,524
|
|
-
|
2,524
|
Effect of application of IAS 29
(hyperinflation)
|
-
|
-
|
-
|
361,455
|
-
|
361,455
|
|
-
|
361,455
|
Gains/(losses) of controlling
interest´s share
|
-
|
-
|
-
|
-
|
-
|
-
|
|
107,030
|
107,030
|
Paid dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
|
(20,153)
|
(20,153)
|
Purchase of shares and results from
treasury shares
|
-
|
302
|
-
|
-
|
-
|
302
|
|
-
|
302
|
Share-based payments
|
-
|
45,009
|
-
|
-
|
-
|
45,009
|
|
-
|
45,009
|
At March 31, 2019
|
57,798,844
|
54,740,387
|
15,341,367
|
3,023,305
|
(71,795,387)
|
59,108,516
|
|
1,382,121
|
60,490,637
|
The
accompanying notes are an integral part of these interim consolidated financial
statements.
5
AMBEV
S.A.
Interim Consolidated Statements
of Changes in Equity
For the period ended
March 31
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
Attributable to equity holders of Ambev
|
|
|
|
|
Capital
|
Capital reserves
|
Net income reserves
|
Retained earnings
|
Carrying value
adjustments
|
Total
|
|
Non-controlling
interests
|
Total
equity
|
At December 31, 2019
|
57,866,759
|
54,811,462
|
20,874,268
|
-
|
(72,274,464)
|
61,278,025
|
|
1,277,980
|
62,556,005
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
-
|
-
|
-
|
1,091,784
|
-
|
1,091,784
|
|
119,468
|
1,211,252
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
Gains/(losses) on translation of
foreign operations
|
-
|
-
|
-
|
-
|
7,103,805
|
7,103,805
|
|
376,026
|
7,479,831
|
Cash flow hedges
|
-
|
-
|
-
|
-
|
543,944
|
543,944
|
|
(1,112)
|
542,832
|
Actuarial gains/(losses)
|
-
|
-
|
-
|
-
|
(4,698)
|
(4,698)
|
|
(56)
|
(4,754)
|
Total comprehensive income
|
-
|
-
|
-
|
1,091,784
|
7,643,051
|
8,734,835
|
|
494,326
|
9,229,161
|
Capital increase (Note 13)
|
32,314
|
(32,314)
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Effect of application of IAS 29
(hyperinflation)
|
-
|
-
|
-
|
300,195
|
-
|
300,195
|
|
(566)
|
299,629
|
Gains/(losses) of controlling
interest´s share
|
-
|
-
|
-
|
-
|
(756)
|
(756)
|
|
1,109
|
353
|
Tax on deemed dividends
|
-
|
-
|
-
|
-
|
(772)
|
(772)
|
|
-
|
(772)
|
Paid dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
|
(23,685)
|
(23,685)
|
Purchase of shares and results from
treasury shares
|
-
|
(2,150)
|
-
|
-
|
-
|
(2,150)
|
|
-
|
(2,150)
|
Share-based payments
|
-
|
50,529
|
-
|
-
|
-
|
50,529
|
|
-
|
50,529
|
At March 31, 2020
|
57,899,073
|
54,827,527
|
20,874,268
|
1,391,979
|
(64,632,941)
|
70,359,906
|
|
1,749,164
|
72,109,070
|
The
accompanying notes are an integral part of these interim consolidated financial
statements.
6
AMBEV S.A.
Interim Consolidated Cash Flow Statements
For the period ended March 31
All amounts in thousand of Brazilian Reais unless otherwise stated
|
Note
|
2020
|
2019
|
|
|
|
|
Net income
|
|
1,211,252
|
2,749,068
|
Depreciation, amortization and impairment
|
|
1,174,012
|
1,046,498
|
Impairment losses on receivables and inventories
|
|
53,540
|
45,148
|
Additions/(reversals) in provisions and employee benefits
|
|
19,373
|
14,812
|
Net finance cost
|
17
|
1,536,867
|
672,068
|
Losses/(gain) on sale of property, plant and equipment and intangible assets
|
|
(27,337)
|
(11,800)
|
Equity-settled share-based payment expense
|
19
|
51,797
|
45,402
|
Income tax expense
|
18
|
279,668
|
632,461
|
Share of result of joint ventures
|
|
6,617
|
2,136
|
Other non-cash items included in the profit
|
|
(346,778)
|
(438,793)
|
Cash flow from operating activities before changes in working capital and use of provisions
|
|
3,959,011
|
4,757,000
|
|
|
|
|
(Increase)/decrease in trade and other receivables
|
|
2,665,860
|
687,221
|
(Increase)/decrease in inventories
|
|
(1,142,700)
|
(666,025)
|
Increase/(decrease) in trade and other payables
|
|
(2,518,292)
|
(1,222,901)
|
Cash generated from operations
|
|
2,963,879
|
3,555,295
|
|
|
|
|
Interest paid
|
|
(132,971)
|
(73,176)
|
Interest received
|
|
133,746
|
132,991
|
Dividends received
|
|
937
|
245
|
Income tax paid
|
|
(1,421,534)
|
(1,535,210)
|
Cash flow from operating activities
|
|
1,544,057
|
2,080,145
|
|
|
|
|
Proceeds from the sale of property, plant and equipment and intangible assets
|
|
30,232
|
19,831
|
Acquisitions of property, plant and equipment and intangible assets
|
|
(1,346,319)
|
(546,056)
|
Acquisitions of subsidiaries, net of cash acquired
|
|
(279,327)
|
(44,562)
|
Acquisitions of other investments
|
|
-
|
-
|
Investment in short term debt securities and net proceeds/(acquisitions) of debt securities
|
|
(75,278)
|
(14,644)
|
Net proceeds/(acquisitions) of other assets
|
|
-
|
202,296
|
Cash flow from investing activities
|
|
(1,670,692)
|
(383,135)
|
|
|
|
|
Capital increase
|
|
-
|
2,524
|
Capital increase/(decrease) of non-controlling interest
|
|
659
|
-
|
Proceeds/(repurchase) of treasury shares
|
|
(4,467)
|
(1,333)
|
Acquisition of non-controlling interest
|
|
-
|
(34)
|
Proceeds from borrowings
|
|
86,549
|
801,611
|
Repayment of borrowings
|
|
(46,938)
|
(92,395)
|
Cash net of finance expenses other than interest
|
|
(8,147)
|
(886,701)
|
Payment of lease liabilities
|
|
(128,690)
|
(154,496)
|
Dividends and Interest on shareholder´s equity paid
|
|
(46,548)
|
(53,007)
|
Cash flow from financing activities
|
|
(147,582)
|
(383,831)
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents
|
|
(274,217)
|
1,313,179
|
Cash and cash equivalents less bank overdrafts at the beginning of the year (i)
|
|
11,900,642
|
11,463,498
|
Effect of exchange rate fluctuations
|
|
1,578,047
|
45,847
|
Cash and cash equivalents less bank overdrafts at the end of the year (i)
|
|
13,204,472
|
12,822,524
|
(i) Net of bank overdrafts.
The accompanying notes are an integral part of these interim consolidated financial statements.
7
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
1.
|
Corporate information
|
2.
|
Statement of compliance
|
3.
|
Summary of significant accounting
policies
|
4.
|
Use of estimates and judgments
|
5.
|
Cash and cash equivalents
|
6.
|
Investment securities
|
7.
|
Inventories
|
8.
|
Deferred income tax and social
contribution
|
9.
|
Property, plant and equipment
|
10.
|
Goodwill
|
11.
|
Interest-bearing loans and
borrowings
|
12.
|
Provisions
|
13.
|
Changes in equity
|
14.
|
Segment reporting
|
15.
|
Net sales
|
16.
|
Other operating income/(expenses)
|
17.
|
Exceptional items
|
18.
|
Finance expenses and income
|
19.
|
Income tax and social contribution
|
20.
|
Share-based payments
|
21.
|
Financial instruments and risks
|
22.
|
Collateral and contractual commitments with suppliers, advances from customers and
other
|
23.
|
Contingent liability
|
24.
|
Non-cash items
|
25.
|
Related parties
|
26.
|
Events after the reporting
period
|
8
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
1. CORPORATE
INFORMATION
(a)
Description of business
Ambev S.A.
(referred to as “the Company” or “Ambev”), is headquartered in São Paulo,
Brazil, and either directly or through participation in other companies,
produces and sells beer, draft beer, soft drinks, other non-alcoholic beverages,
malt and food in general, as well as advertising its own and third-party
products, selling promotional and advertising materials and directly or
indirectly exploiting bars, restaurants, snack bars and other
establishments.
The Company’s shares and ADRs
(American Depositary Receipts) are listed on the B3 S.A.- Brasil, Bolsa, Balcão
as “ABEV3” and on the New York Stock Exchange (NYSE) as “ABEV”,
respectively.
The Company’s
direct controlling shareholders are Interbrew International B.V. (“IIBV”),
AmBrew S.A. (“Ambrew”), both subsidiaries of Anheuser-Busch InBev N.V. (“AB
InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de
Beneficência (“Fundação Zerrenner”).
The interim
financial statements were approved by the Board of Directors on May 6,
2020.
(b)
Major corporate events in 2020 and 2019:
COVID-19
impacts
The outbreak
of the new coronavirus (SARS-CoV-2) on a global scale has increased the
volatility of the national and international markets and has affected the
economies of the countries in which we operate and, consequently, the results of
our operations. The response to the COVID-19 pandemic has developed rapidly
across the globe in a fluid and uncertain manner. In addition to voluntary and,
in some cases, mandatory quarantines, restrictions on travel, on commercial and
social activities, among others, as well as a ban on the distribution, sale and
consumption of alcoholic beverages in some markets where we operate, are
directly affecting our sales and distribution of products available and
generating direct impacts on final consumer demand for our products.
9
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
The
COVID-19 pandemic and the restrictions imposed by each government in response
have generated, especially since March 2020, significant changes in market
dynamics both in the off-trade sales channel, composed of supermarkets, and in
the on-trade channel, which is composed of bars and restaurants. In countries
with a higher level of income, a more mature beer market and a greater weight of
the off-trade sales channel, such as Canada, we observed the behavior of
stockpiled as consequenses increase our volume in the initial moment of the
crisis. On the other hand, in countries with lower income levels and less mature
beer market, volume has been impacted according to the market segmentation
between the on-trade and off-trade channels; in those cases, the volume
reduction is higher depending on the weight of the on-trade channel. In
addition, we observed an increase in sales via e-commerce in all countries,
although this channel represents only a small portion of the Company's volume.
Although the restrictions imposed by each government on
commercial and operational activities, on the circulation of people and on the
sale, distribution and consumption of alcoholic beverages are currently
considered temporary, there is uncertainty related to their duration, the
possibility of any government intervention or the imposition of other measures,
as well as the economic effects on the financial market, exchange rates, among
others. Those impacts may result in material adverse effects on our business,
liquidity, financial condition, and results of operations, as well as volatility
in the trading price of our shares. Therefore, the extent of COVID-19's impacts
on our business depends on future developments, which are highly uncertain and
unpredictable, in addition to being out of our control, even with the
possibility of new information on the severity of the virus, the scope of the
outbreak and the actions necessary to contain the pandemic or treat its impact,
among others.
The Company's
management performed a set of analyses on the impact of COVID-19, which involved
(i) a review of the assumptions of the annual impairment test, (ii) analysis of
possible credit losses and inventory obsolescence, (iii) a review of the
measurement assumptions of financial instruments, including hedges, (iv)
analysis of the recoverability of deferred taxes, and (v) evaluation of the
relevant estimates used in the preparation of the interim financial statements,
among other analyses.
Any impacts
derived from these analyses are reflected in the financial statements and
explanatory notes, which include the accounting for exceptional items,
totalizing R$10 million in the first quarter of 2020, as presented in Note
17.
10
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
New
acquisitions
On January 22,
2020, the company acquired G&W Distilling Inc., a company that produces a
portfolio of ready-to-drink alcoholic beverages, through our subsidiary Labatt
Brewing Company Limited.
Red Bull distribution contract
On November 7,
2019, the company entered into a long-term distribution agreement with Red Bull
do Brasil Ltda. (“Red Bull”), whereby we have been granted the exclusive right
to sell and distribute certain brands of Red Bull’s portfolio in specific
limited points of sale for the on-trade channel in Brazil. We also have
agreements with Red Bull to distribute their portfolio in a few limited channels
in Argentina and the Dominican Republic.
Information
released by the press
In the third
quarter of 2019, there were news reports based on alleged leaks of statements by
Mr. Antonio Palocci in a legal procedure, to which the Company subsequently had
access. As previously stated in a press release dated August 9, 2019, the
Company, consistent with its Code of Business Conduct and principles, has
remained committed to reviewing and monitoring this matter. In this regard, the
Company has not identified evidence supporting Mr. Palocci’s claims of illegal
conduct by Ambev.
The Company
reiterates its commitment to conducting business in a legal and ethical manner,
and it will continue to monitor this matter and will respond as appropriate to
any requests from authorities.
Exchange
contracts for future financial flows - equity swap
On December
20, 2018 Ambev's Board of Directors approved the execution, by the Company or
its subsidiaries, of equity swap contracts through financial institutions to be
defined by the Company's management, having as underlying asset the shares
issued by the Company or ADRs, without losses on the liquidation, within the
regulatory term, of the contracts still in force. The settlement of the approved
equity swap contracts will occur within a maximum period of 18 months from
approval; such contracts may result in exposure up to 80 million common shares
(which all or part may be through ADRs), with a limit value up to R$1.5
billion.
11
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
On May 15,
2019, the Board of Directors of Ambev approved the conclusion of new equity-swap
contracts, without losses upon liquidation, within the regulatory term, of the
equity-swap contracts still in force. The settlement of the newly approved
equity-swap contracts will occur within a maximum period of 18 months from the
date of approval, and such contracts may result in an exposure of up to 80
million common shares (of which all or part may be in the form of ADRs), up to a
value limit value of R$1.5 billion.
On December
19, 2019, the Board of Directors of Ambev approved new equity-swap contracts,
without prejudice to the liquidation, within the regulatory term, of the
equity-swap contracts still in force. The settlement of the new approved
equity-swap contracts will occur within a maximum period of 18 months from the
date of approval, and such contracts may result in an exposure of up to 80
million common shares (of which all or part may be in the form of ADRs), up to a
value limit of R$1.5 billion, in addition to contracts already executed in the
context of the approvals of December 20, 2018 and May 15, 2019, and which have
not yet been settled as at the date of approval, may result in an exposure of up
to 217,014,453 common shares (all or part of which may be in the form of
ADRs).
Addendum to
the agreement with PepsiCo
The long-term
agreement with PepsiCo, under which the Company has the exclusive right to
bottle, sell and distribute certain brands on PepsiCo’s portfolio of soft drinks
in Brazil, including Pepsi Cola, Gatorade, H2OH! and Lipton Ice Tea, was amended
in October 2018 to reflect certain changes in the trade agreement between the
parties. The new terms of the agreement were approved by CADE in December 2018
and became effective as of January 1, 2019. The
agreement will be in force until December 31, 2027.
2. STATEMENT OF
COMPLIANCE
The
consolidated interim financial statements have been prepared using the
accounting basis of going concern and are being presented in accordance with IAS
34 - Interim Financial Reporting as issued by the International Accounting
Standards Board (“IASB”).
The
information does not meet all disclosure requirements for the presentation of
full annual financial statements and thus should be read in conjunction with the
consolidated financial statements prepared in accordance with International
Financial Reporting Standards (“IFRS”) for the year ended December 31, 2019. To
avoid duplication of disclosures which are included in the annual financial
statements, the following notes were not subject to full filling:
12
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
(a)
|
Summary of significant accounting policies (Note 3);
|
(b)
|
Trade receivables (Note 19);
|
(c)
|
Investments securities (Note 16);
|
(d)
|
Intangible (Note 15);
|
(e)
|
Goodwill (Note 14);
|
(f)
|
Trade payables (Note 25);
|
(g)
|
Interest-bearing loans and borrowings (Note 22);
|
(h)
|
Employee benefits (Note 23);
|
(i)
|
Changes in equity (Note 21);
|
(j)
|
Additional information on operating expenses by nature (Note 10);
|
(k)
|
Payroll and related benefits (Note 09);
|
(l)
|
Contingent liabilities (Note 29);
|
(m)
|
Group Companies (Note 32);
|
(n)
|
Insurance (Note 33)
|
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
There were no significant changes in accounting policies and calculation methods used for the interim financial statements as at March 31, 2020, in relation to those presented in the financial statements for the year ended December 31, 2019.
(a) Basis of preparation and measurement
The interim financial statements are presented in thousands of Brazilian Real (“R$”), unless otherwise indicated, rounded to the nearest thousand indicated. Depending on the applicable IFRS requirement, the measurement basis used in preparing the interim financial statements is historical cost, net realizable value, fair value or recoverable amount.
(b) Recently issued IFRS
There were no new standards for the period ended March 31, 2020 for the preparation of these interim financial statements.
Other standards, interpretations and amendments to standards
There are no other standards, interpretations and amendments to standards that are not yet effective that would be expected to have material impact on the Company consolidated interim financial information.
13
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
4. USE OF
ESTIMATES AND JUDGMENTS
The preparation of interim financial statements in
conformity with IFRS requires Management to make judgments, estimates and
assumptions that affect the application of accounting practices and the reported
amounts of assets and liabilities, income and expenses. The estimates and
judgments are based on past experience and various other factors that are
believed to be reasonable under the circumstances, the results of which form the
basis for decision making regarding the judgments about carrying amounts of
assets and liabilities that are not readily evident from other sources. Actual
results may differ from these estimates.
The estimates and assumptions are reviewed on a regular
basis. Changes in accounting estimates may affect the period in which they are
realized, or future periods.
Although each of its significant accounting policies
reflects judgments, assessments or estimates, the Company believes that the
following accounting practices reflect the most critical judgments, estimates
and assumptions that are important to its business operations and the
understanding of its results:
(i) predecessor accounting;
(ii) business combinations;
(iii) impairment;
(iv) provisions;
(v) share-based payments;
(vi) employee benefits;
(vii) current and deferred tax;
(viii) joint arrangements;
(ix) measurement of financial instruments, including
derivatives;
(x) inflation accounting and financial reporting in
hyperinflationary economies; and
(xi) leasing
The fair
values of acquired identifiable intangibles of indefinite useful life are based
on an assessment of future cash flows. Impairment analyses of goodwill and
intangible assets with an indefinite life are performed at least annually and
whenever a triggering event occurs, in order to determine whether the carrying
value exceeds the recoverable amount.
The Company
uses its judgment to select a variety of methods including the net fair value of
expenses approach and option valuation models and makes assumptions about the
fair
14
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
value of financial instruments that are mainly based on market conditions existing at each balance sheet date.
Actuarial assumptions are established to anticipate future events and are used in calculating pension and other long-term employee benefit expense and liability. These factors include assumptions with respect to interest rates, rates of increase in health care costs, rates of future compensation increases, turnover rates, and life expectancy. Such estimates are reviewed annually by independent actuaries.
The Company is subject to income tax in numerous jurisdictions. Significant judgment is required in determining the worldwide provision for income tax. There are some transactions and calculations for which the ultimate tax determination is uncertain. Some subsidiaries within the Company are involved in tax audits usually in relation to prior years. These audits are ongoing in various jurisdictions at the balance sheet date and, by their nature, these can take considerable time until their conclusion.
5. CASH AND CASH EQUIVALENTS
|
03/31/2020
|
12/31/2019
|
|
|
|
Cash
|
77,227
|
207,529
|
Bank accounts
|
4,907,668
|
5,403,536
|
Short term bank deposits (i)
|
8,219,577
|
6,289,601
|
Cash and cash equivalents
|
13,204,472
|
11,900,666
|
|
|
|
Bank overdrafts
|
-
|
(24)
|
Cash and cash equivalents less bank overdraft
|
13,204,472
|
11,900,642
|
(i) The balance refers mostly to bank deposit certificates – (CDB), which have a high liquidity, are readily convertible into known amounts of cash and are subject to an insignificant risk of change in value.
Current account balances included guarantee deposits in the amount of R$452 million as at March 31, 2020 (R$348 million on December 31, 2019) held by the subsidiary of Cuba, which are not freely transferable to the parent company for reasons of exchange restrictions.
6. INVESTMENTS SECURITIES
|
03/31/2020
|
12/31/2019
|
|
|
|
Financial asset at fair value through profit or loss-held for trading
|
44,823
|
14,558
|
Current investments securities
|
44,823
|
14,558
|
|
|
|
Investment on debt securities (i)
|
200,856
|
163,570
|
Non-current investments securities
|
200,856
|
163,570
|
|
|
|
Total
|
245,679
|
178,128
|
15
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(i) The balance refers
substantially to CDB linked to tax incentives and do not have
an immediate convertibility in a known
amount of cash.
16
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
7. INVENTORIES
|
03/31/2020
|
12/31/2019
|
|
|
|
Finished goods
|
3,153,514
|
2,080,668
|
Work in progress
|
439,445
|
450,807
|
Raw material and consumables
|
3,318,517
|
2,637,360
|
Spare parts and other
|
712,402
|
602,548
|
Prepayments
|
259,529
|
328,347
|
Impairment losses
|
(130,751)
|
(121,173)
|
|
7,752,656
|
5,978,557
|
Write-offs and
losses on inventories recognized in the income statement amounted to R$34,330 in
the period ended on March 31, 2020 (R$31,081 in the period ended on March 31,
2019).
8. DEFERRED
INCOME TAX AND SOCIAL CONTRIBUTION
Deferred taxes for income tax and
social contribution taxes are calculated on temporary differences between the
tax bases of these taxes and the accounting calculation of the Company, among
which, tax losses. The rates of these taxes in Brazil, which are expected at the
realization of deferred taxes, are 25% for income tax and 9% for social
contribution. For the other regions in which the Company operates, the expected
rates are as follow:
Central America and the Caribbean
|
from 15% to
27%
|
Latin America - South (i)
|
from 10% to
30%
|
Canada
|
26.5%
|
(i) Amendments
to Argentine tax legislation approved on December 29, 2017 affected the Company
beginning in October 2018 and reduced the income tax rate in the first two years
from 35% to 30% and, after, to 25%. Further, new amendments to the Argentine tax
legislation approved on December 23, 2019 postponed for one year the application
of the income tax rate of rate of 25% and extended for a third year the
application of the 30% rate.
Deferred tax
assets are recognized to the extent that it is probable that future taxable
profit is probable, which may be offset against temporary differences recorded
currently, with a special emphasis on tax losses.
17
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
The amount of deferred income tax and social contribution by type of temporary difference is detailed as follows:
|
03/31/2020
|
|
12/31/2019
|
|
Assets
|
Liabilities
|
Net
|
|
Assets
|
Liabilities
|
Net
|
Investment securities
|
10,059
|
-
|
10,059
|
|
10,007
|
-
|
10,007
|
Intangible
|
-
|
(1,345,695)
|
(1,345,695)
|
|
-
|
(1,067,471)
|
(1,067,471)
|
Employee benefits
|
834,694
|
(4,783)
|
829,911
|
|
749,988
|
(3,950)
|
746,038
|
Trade payables
|
3,453,324
|
(235,236)
|
3,218,088
|
|
2,330,349
|
(246,651)
|
2,083,698
|
Trade receivable
|
59,699
|
-
|
59,699
|
|
45,513
|
(3,267)
|
42,246
|
Derivatives
|
36,330
|
(529,004)
|
(492,674)
|
|
38,873
|
(217,204)
|
(178,331)
|
Interest-Bearing Loans and Borrowings
|
-
|
(26)
|
(26)
|
|
-
|
(23)
|
(23)
|
Inventories
|
318,946
|
(130,299)
|
188,647
|
|
372,014
|
(67,066)
|
304,948
|
Property, plant and equipment
|
362,844
|
(1,540,269)
|
(1,177,425)
|
|
290,383
|
(1,423,367)
|
(1,132,984)
|
Withholding tax over undistributed profits and royalties
|
-
|
(1,279,172)
|
(1,279,172)
|
|
-
|
(1,115,123)
|
(1,115,123)
|
Investments in joint ventures
|
-
|
(421,589)
|
(421,589)
|
|
-
|
(421,589)
|
(421,589)
|
Interest on shareholders' equity
|
141,389
|
-
|
141,389
|
|
-
|
-
|
-
|
Loss carry forwards
|
1,021,455
|
(177,253)
|
844,202
|
|
877,308
|
(148,350)
|
728,958
|
Provisions
|
484,192
|
(6,331)
|
477,861
|
|
465,863
|
(2,284)
|
463,579
|
Complement of income tax of foreign subsidiaries due in Brazil
|
-
|
(17,941)
|
(17,941)
|
|
-
|
-
|
-
|
Impact of the adoption of IFRS 16 (leasing operations)
|
51,228
|
(1,916)
|
49,312
|
|
44,587
|
(1,910)
|
42,677
|
Other items
|
122,580
|
(20,824)
|
101,756
|
|
88,979
|
(16,598)
|
72,381
|
Gross deferred tax assets / (liabilities)
|
6,896,740
|
(5,710,338)
|
1,186,402
|
|
5,313,864
|
(4,734,853)
|
579,011
|
Netting by taxable entity
|
(2,848,551)
|
2,848,551
|
-
|
|
(2,363,755)
|
2,363,755
|
-
|
Net deferred tax assets / (liabilities)
|
4,048,189
|
(2,861,787)
|
1,186,402
|
|
2,950,109
|
(2,371,098)
|
579,011
|
|
|
|
|
|
|
|
|
The Company only offsets the balances of deferred income tax and social contribution assets against liabilities to net presentation when they are within the same entity, of the same nature and expected to be realized in the same period.
The critical estimates of Ambev’s Management, as well the main contingent liabilities related to uncertainties about the tax treatment of income, are disclosed in Notes 4 and 23, respectively.
18
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
At March 31,
2020 the assets and liabilities deferred taxes related to combined tax losses
had an expected utilization or settlement by temporary differences as
follows:
|
03/31/2020
|
Deferred taxes not related to tax
losses
|
to be
realized until 12 months
|
to be
realized after 12 months
|
Total
|
|
|
|
|
Investment securities
|
-
|
10,059
|
10,059
|
Intangible
|
(1,483)
|
(1,344,212)
|
(1,345,695)
|
Employee benefits
|
63,688
|
766,223
|
829,911
|
Trade payables
|
(195,458)
|
3,413,546
|
3,218,088
|
Trade receivable
|
49,030
|
10,669
|
59,699
|
Derivatives
|
(100,685)
|
(391,989)
|
(492,674)
|
Interest-bearing loans and
borrowings
|
(13)
|
(13)
|
(26)
|
Inventories
|
203,740
|
(15,093)
|
188,647
|
Property, plant and equipment
|
(119,354)
|
(1,058,071)
|
(1,177,425)
|
Withholding tax over undistributed
profits and royalties
|
(118,771)
|
(1,160,401)
|
(1,279,172)
|
Investments in joint ventures
|
-
|
(421,589)
|
(421,589)
|
Interest on shareholders' equity
|
141,389
|
-
|
141,389
|
Provisions
|
259,612
|
218,249
|
477,861
|
Complement of income tax of foreign
subsidiaries due in Brazil
|
(17,941)
|
-
|
(17,941)
|
Impact of the adoption of IFRS 16
(leasing operations)
|
(804)
|
50,116
|
49,312
|
Other items
|
37,695
|
64,061
|
101,756
|
Total
|
200,645
|
141,555
|
342,200
|
Most tax
losses and negative social contribution bases on which deferred income tax and
social contribution were calculated do not have a limitation period. Their use
is based on the projection of the future existence of taxable profits, according
to past performance and to the projections of the Company's business in the
economies where it is located, in compliance with the applicable fiscal and
accounting rules.
Deferred tax related to tax
losses
|
03/31/2020
|
2020
|
244,111
|
2021
|
373,475
|
2022
|
54,013
|
2023
|
10,632
|
2024 to 2026
|
135,980
|
2027 to 2029 (i)
|
25,991
|
Total
|
844,202
|
(i) There is no
expectation of realization that exceeds the term of 10 years.
As at March
31, 2020, there were deferred tax assets in the amount of R$902,842 (R$707,102
in December 31, 2019) related to tax losses that were not recorded as the
realization was not probable.
19
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
The major part
of the tax losses does not have a carryforward limit for utilization and the tax
losses carried forward in relation to the credit were equivalent to R$3,581,309
on March 31, 2020 (R$2,811,614 in December 31, 2019).
The net change
in deferred income tax and social contribution is detailed as
follows:
At December 31, 2019
|
579,011
|
Recognition of
actuarial gains/(losses)
|
(5,133)
|
Investment hedge - put
option of a subsidiary interest
|
296,199
|
Cash flow hedge
- gains/(losses)
|
(279,292)
|
Gains/(losses) on
translation of other foreign operations
|
609,809
|
Recognized in other comprehensive
income
|
621,583
|
Recognized in the income
statement
|
15,365
|
Changes directly in the balance
sheet
|
(29,557)
|
Recognized in deferred tax
|
(30,906)
|
Effect of application of IAS 29
(hyperinflation)
|
(30,906)
|
Recognized in other group of balance
sheet
|
1,349
|
At March 31, 2020
|
1,186,402
|
20
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
9.
PROPERTY, PLANT AND EQUIPMENT
|
03/31/2020
|
12/31/2019
|
Property, plant and equipment
|
22,762,695
|
20,547,670
|
Right of use assets
|
2,300,741
|
2,028,629
|
|
25,063,436
|
22,576,299
|
|
03/31/2020
|
|
12/31/2019
|
|
Land and
buildings
|
Plant and
equipment
|
Fixtures and
fittings
|
Under
construction
|
Total
|
|
Total
|
Acquisition cost
|
|
|
|
|
|
|
|
Balance at the end of the previous
year
|
10,886,903
|
29,676,067
|
6,367,458
|
2,184,297
|
49,114,725
|
|
45,563,614
|
Effect of movements in foreign exchange
in balance sheet
|
883,787
|
2,549,010
|
645,798
|
220,204
|
4,298,799
|
|
(1,540,649)
|
Effect of application of IAS 29
(hyperinflation)
|
45,567
|
143,242
|
(9,063)
|
5,455
|
185,201
|
|
1,871,985
|
Acquisition through business
combinations
|
1,217
|
5,571
|
1,095
|
-
|
7,883
|
|
7,984
|
Acquisitions
|
1,572
|
111,962
|
20,358
|
1,029,769
|
1,163,661
|
|
4,475,932
|
Disposals and write-off
|
(3,571)
|
(123,300)
|
(12,199)
|
(238)
|
(139,308)
|
|
(906,075)
|
Transfer to other asset
categories
|
181,887
|
288,619
|
122,868
|
(703,194)
|
(109,820)
|
|
(358,081)
|
Others
|
-
|
-
|
-
|
-
|
-
|
|
15
|
Balance at the end of the
year
|
11,997,362
|
32,651,171
|
7,136,315
|
2,736,293
|
54,521,141
|
|
49,114,725
|
|
|
|
|
|
|
|
|
Depreciation and Impairment
|
|
|
|
|
|
|
|
Balance at the end of the previous
year
|
(3,400,533)
|
(20,381,204)
|
(4,785,318)
|
-
|
(28,567,055)
|
|
(25,463,196)
|
Effect of movements in foreign exchange
in balance sheet
|
(192,978)
|
(1,684,101)
|
(476,651)
|
-
|
(2,353,730)
|
|
810,836
|
Effect of application of IAS 29
(hyperinflation)
|
4,566
|
26,307
|
(56,777)
|
-
|
(25,904)
|
|
(1,025,261)
|
Depreciation
|
(92,408)
|
(657,937)
|
(170,692)
|
-
|
(921,037)
|
|
(3,530,161)
|
Impairment losses
|
(6)
|
(24,160)
|
(22)
|
-
|
(24,188)
|
|
(153,035)
|
Disposals and write-off
|
1,066
|
118,218
|
11,976
|
-
|
131,260
|
|
783,951
|
Transfers to other asset
categories
|
(326)
|
(419)
|
822
|
-
|
77
|
|
237
|
Others
|
-
|
2,131
|
-
|
-
|
2,131
|
|
9,574
|
Balance at the end of the
year
|
(3,680,619)
|
(22,601,165)
|
(5,476,662)
|
-
|
(31,758,446)
|
|
(28,567,055)
|
Carrying amount:
|
|
|
|
|
|
|
|
December 31, 2019
|
7,486,370
|
9,294,863
|
1,582,140
|
2,184,297
|
20,547,670
|
|
20,547,670
|
March 31, 2020
|
8,316,743
|
10,050,006
|
1,659,653
|
2,736,293
|
22,762,695
|
|
|
|
|
|
|
|
|
|
|
21
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
Capitalized interests and fixed assets provided as security are not material.
Right-of-use asset:
|
03/31/2020
|
|
12/31/2019
|
|
Buildings
|
Machinery and equipment
|
Others
|
Total
|
|
Total
|
Acquisition cost
|
|
|
|
|
|
|
Balance at the end of the previous year
|
1,871,148
|
1,385,167
|
104,786
|
3,361,101
|
|
2,394,070
|
Effect of movements in foreign exchange in balance sheet
|
104,107
|
5,988
|
7,269
|
117,364
|
|
19,523
|
Additions
|
310,202
|
19,781
|
2,817
|
332,800
|
|
898,843
|
Transfer from (to) other asset categories
|
(1,349)
|
-
|
-
|
(1,349)
|
|
48,665
|
Balance at the end of the year
|
2,284,108
|
1,410,936
|
114,872
|
3,809,916
|
|
3,361,101
|
|
|
|
|
|
|
|
Depreciation and Impairment
|
|
|
|
|
|
|
Balance at the end of the previous year
|
(494,488)
|
(756,906)
|
(81,078)
|
(1,332,472)
|
|
(856,480)
|
Effect of movements in foreign exchange in balance sheet
|
(32,050)
|
(2,128)
|
(2,745)
|
(36,923)
|
|
(5,675)
|
Depreciation
|
(67,416)
|
(65,575)
|
(7,719)
|
(140,710)
|
|
(467,267)
|
Transfer (from) to other asset categories
|
(2,019)
|
2,949
|
-
|
930
|
|
(3,050)
|
Balance at the end of the year
|
(595,973)
|
(821,660)
|
(91,542)
|
(1,509,175)
|
|
(1,332,472)
|
Carrying amount:
|
|
|
|
|
|
|
At December 31, 2018
|
1,376,660
|
628,261
|
23,708
|
2,028,629
|
|
2,028,629
|
At March 31, 2019
|
1,688,135
|
589,276
|
23,330
|
2,300,741
|
|
|
The Company estimated discount rates, based on risk-free interest rates observed in the Brazilian market, for the terms of its contracts, adjusted to its reality (credit spread). Spreads were obtained with financial institutions. The following table shows the rates applied:
Lease Term
|
Rate %
|
2020 - 2025
|
6.627%
|
2026 - 2030
|
8.329%
|
2031 - 2035
|
8.858%
|
10. GOODWILL
|
03/31/2020
|
12/31/2019
|
|
|
|
Balance at the end of the previous year
|
35,009,909
|
34,276,176
|
Effect of movements in foreign exchange in balance sheet
|
3,842,426
|
16,086
|
Effect of application of IAS 29 (hyperinflation)
|
139,610
|
691,198
|
Acquisition, (write-off) and disposal through business combinations
|
358,879
|
26,449
|
Balance at the end of the year
|
39,350,824
|
35,009,909
|
22
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
The carrying
amount of goodwill was allocated to the different cash-generating units as
follows:
|
Functional currency
|
03/31/2020
|
12/31/2019
|
|
|
|
|
Brazil
|
BRL
|
17,694,842
|
17,694,842
|
Goodwill
|
|
102,937,475
|
102,937,475
|
Non-controlling transactions
(i)
|
|
(85,242,633)
|
(85,242,633)
|
|
|
|
|
CAC:
|
|
|
|
Dominican Republic
|
DOP
|
4,404,965
|
3,476,862
|
Panama
|
PAB
|
1,807,166
|
1,400,457
|
|
|
|
|
Latin America - South:
|
|
|
|
Argentina
|
ARS
|
2,502,755
|
1,972,177
|
Bolivia
|
BOB
|
1,838,893
|
1,425,746
|
Chile
|
CLP
|
53,742
|
47,322
|
Paraguay
|
PYG
|
1,059,861
|
836,593
|
Uruguay
|
UYU
|
179,270
|
160,108
|
|
|
|
|
Canada
|
CAD
|
9,809,330
|
7,995,802
|
|
|
39,350,824
|
35,009,909
|
(i) This refers to the exchange of
the shareholdings operation that occurred in 2013 as a result of the adoption of
the predecessor basis of accounting.
11. INTEREST-BEARING LOANS AND BORROWINGS
|
03/31/2020
|
12/31/2019
|
|
|
|
Secured bank loans
|
210,731
|
176,673
|
Unsecured bank loans
|
52,126
|
94
|
Other unsecured loans
|
38,629
|
40,378
|
Lease liabilities
|
478,604
|
436,004
|
Current liabilities
|
780,090
|
653,149
|
|
|
|
Secured bank loans
|
262,654
|
284,481
|
Unsecured bank loans
|
266,770
|
212,574
|
Debentures and unsecured bond issues
|
107,096
|
106,611
|
Other unsecured loans
|
101,458
|
94,088
|
Lease liabilities
|
1,955,382
|
1,711,901
|
Non-current liabilities
|
2,693,360
|
2,409,655
|
Additional
information regarding the exposure of the Company to the risks of interest rate
and foreign-currency changes are disclosed in Note 21 – Financial instruments and risks.
Contractual
clauses (covenants)
As at March
31, 2020, the Company's loans had equal rights to payment without subordination
clauses. Except for the credit lines due to FINAME contracted by the
23
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
Company with Banco Nacional de Desenvolvimento Econômico e Social – BNDES (“BNDES”), where collateral was provided on assets acquired with the credit granted, which served as collateral; other loans and financing contracted by the Company predicted only guarantees as personal collateral or were unsecured. Most loan contracts contained financial covenants covering matters such as limitations on new indebtedness, the Company’s ability to continue as a going-concern, the Company’s assets maintenance, in use or in good condition for the business; restrictions on acquisitions, mergers, sale or disposal of its assets, and disclosure of financial statements; and no constitution of real guarantees for new loans contracted, except if: (i) expressly authorized under the loan agreement; or (ii) in new loans contracted from financial institutions linked to the Brazilian government - including the BNDES or foreign governments; - or foreign governments, multilateral financial institutions (eg World Bank) or institutions located in jurisdictions in which the Company operates.
Additionally, all agreements with BNDES are subject to certain “provisions applicable to agreements entered into with BNDES” (“Provisions”). Such Provisions require the borrower, to obtain prior consent from BNDES if they, for instance, wish to: (i) raise new loans (except for the loans described in the Provisions); (ii) give preference and/or priority to other debts; and/or (iii) dispose of or encumber any items of their fixed assets (except as provided for in the Provisions).
These clauses apply to the extent that the events mentioned produce material adverse effects on the Company and/or its subsidiaries, or the rights of its creditors, and, in the event of any of the events provided in the clauses, the Company may be granted a grace period to resolve such defaults.
As at March 31, 2020, the Company was in compliance with all its contractual obligations for its loans and financing.
24
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
12. PROVISIONS
(a) Provision changes
|
Balance as of December 31, 2019
|
Effect of changes in foreign exchange rates
|
Provisions constituted
|
Provisions used
|
Provisions reversed
|
Balance as of March 31, 2020
|
|
|
|
|
|
|
|
Provision for disputes and litigations
|
|
|
|
|
|
|
Taxes on sales
|
182,339
|
298
|
7,152
|
(2,729)
|
(5,312)
|
181,748
|
Labor
|
120,127
|
3,118
|
38,994
|
(31,320)
|
(2,080)
|
128,839
|
Civil
|
64,023
|
3,961
|
9,278
|
(11,003)
|
(2,839)
|
63,420
|
Others
|
105,907
|
3,224
|
2,306
|
(2,474)
|
(5,931)
|
103,032
|
Total provision for disputes and litigations
|
472,396
|
10,601
|
57,730
|
(47,526)
|
(16,162)
|
477,039
|
|
|
|
|
|
|
|
Restructuring
|
8,609
|
1,512
|
-
|
-
|
-
|
10,121
|
|
|
|
|
|
|
|
Total provisions
|
481,005
|
12,113
|
57,730
|
(47,526)
|
(16,162)
|
487,160
|
(b) The provisions are expected to be settled within the following time windows
|
Balance as of March 31, 2020
|
1 year or less
|
1-2 years
|
2-5 years
|
Over 5 years
|
|
|
|
|
|
|
Provision for disputes and litigations
|
|
|
|
|
|
Taxes on sales
|
181,748
|
44,683
|
126,974
|
2,363
|
7,728
|
Income tax
|
-
|
-
|
-
|
-
|
-
|
Labor
|
128,839
|
27,478
|
43,916
|
31,197
|
26,248
|
Civil
|
63,420
|
19,325
|
34,934
|
5,854
|
3,307
|
Others
|
103,032
|
20,322
|
22,417
|
57,718
|
2,575
|
Total provision for disputes and litigations
|
477,039
|
111,808
|
228,241
|
97,132
|
39,858
|
|
|
|
|
|
|
Restructuring
|
10,121
|
8,217
|
-
|
1,904
|
-
|
|
|
|
|
|
|
Total provisions
|
487,160
|
120,025
|
228,241
|
99,036
|
39,858
|
The expected settlement of provisions was based on Management’s best estimate at the balance sheet date.
25
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(c) Main
lawsuits with probable likelihood of loss:
(c.1) Income
and Sales taxes
In Brazil, the
Company and its subsidiaries are involved in several administrative and judicial
proceedings related to Income tax, ICMS, IPI, PIS and COFINS taxes. Such
proceedings include, among others, tax offsets, credits and judicial injunctions
exempting tax payment.
(c.2)
Labor
The Company
and its subsidiaries are involved in labor proceedings with former employees,
including from service providers. The main issues involve overtime and related
effects and respective charges.
(c.3)
Civil
The Company is
involved in civil lawsuits with probable likelihood of loss. The most relevant
portion of these lawsuits refers to former distributors, mainly in Brazil, which
are mostly claiming damages resulting from the termination of their
contracts.
The processes
with possible probabilities are disclosed in Note 23 -
Contingent liability.
13. CHANGES
IN EQUITY
(a) Capital
stock
|
|
03/31/2020
|
|
|
03/31/2019
|
|
Thousands
of common shares
|
Thousands
of Real
|
|
Thousands
of common shares
|
Thousands
of Real
|
Beginning balance as per statutory
books
|
15,733,575
|
57,866,759
|
|
15,722,147
|
57,710,202
|
Share issued
|
1,543
|
32,314
|
|
4,695
|
88,642
|
|
15,735,118
|
57,899,073
|
|
15,726,842
|
57,798,844
|
26
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
(b) Capital reserve
|
Capital Reserves
|
|
|
Treasury shares
|
Share Premium
|
Others capital reserves
|
Share-based Payments
|
Total
|
|
|
|
|
|
|
At December 31, 2018
|
(882,734)
|
53,662,811
|
700,898
|
1,300,219
|
54,781,194
|
Capital Increase
|
-
|
-
|
-
|
(86,118)
|
(86,118)
|
Purchase of shares and results from treasury shares
|
302
|
-
|
-
|
-
|
302
|
Share-based payments
|
-
|
-
|
-
|
45,009
|
45,009
|
At March 31, 2019
|
(882,432)
|
53,662,811
|
700,898
|
1,259,110
|
54,740,387
|
|
Capital Reserves
|
|
|
Treasury shares
|
Share Premium
|
Others capital reserves
|
Share-based Payments
|
Total
|
|
|
|
|
|
|
At December 31, 2019
|
(955,135)
|
53,662,811
|
700,898
|
1,402,888
|
54,811,462
|
Capital Increase
|
-
|
-
|
-
|
(32,314)
|
(32,314)
|
Purchase of shares and results from treasury shares
|
(2,150)
|
-
|
-
|
-
|
(2,150)
|
Share-based payments
|
-
|
-
|
-
|
50,529
|
50,529
|
At March 31, 2020
|
(957,285)
|
53,662,811
|
700,898
|
1,421,103
|
54,827,527
|
(b.1) Purchase of shares and result of treasury shares
The treasury shares comprise shares that were previously issued by the Company and then reacquired, and the result on treasury shares that refers to gains and losses related to share-based payment transactions and others.
Below are the changes to treasury shares:
|
Purchase/realization shares
|
|
Result on Treasure Shares
|
|
Total Treasure Shares
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2018
|
1,028
|
|
(20,841)
|
|
(861,893)
|
|
(882,734)
|
Changes during the year
|
(682)
|
|
15,017
|
|
(14,715)
|
|
302
|
At March 31, 2019
|
346
|
|
(5,824)
|
|
(876,608)
|
|
(882,432)
|
|
Purchase/realization shares
|
|
Result on Treasure Shares
|
|
Total Treasure Shares
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
|
|
|
At December 31, 2019
|
3,622
|
|
(68,017)
|
|
(887,118)
|
|
(955,135)
|
Changes during the year
|
(1,590)
|
|
30,953
|
|
(33,103)
|
|
(2,150)
|
At March 31, 2020
|
2,032
|
|
(37,064)
|
|
(920,221)
|
|
(957,285)
|
27
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(b.2) Share
premium
The share
premium refers to the difference between the subscription price that the
shareholders paid for the shares and their nominal value. Since this is a
capital reserve, it can only be used to increase capital, offset losses,
redemptions, reimbursement or repurchase shares.
(b.3)
Share-based payment
Different
share-based payment programs and stock purchase option plans allow the senior
Management from Ambev economic group to acquire shares of the
Company.
The
share-based payment reserve recorded a charge of R$51,797 at March 31, 2020
(R$45,402 at March 31, 2019) (Note 20 – Share-based
payments).
(c) Net income
reserves
|
Net income
reserves
|
|
Investments
reserve
|
Statutory
reserve
|
Fiscal
incentive
|
Total
|
At December 31, 2018
|
6,617,327
|
4,456
|
8,719,584
|
15,341,367
|
|
|
|
|
|
At March 31, 2019
|
6,617,327
|
4,456
|
8,719,584
|
15,341,367
|
|
Net income
reserves
|
|
Investments
reserve
|
Statutory
reserve
|
Fiscal
incentive
|
Total
|
At December 31, 2019
|
10,798,106
|
4,456
|
10,071,706
|
20,874,268
|
|
|
|
|
|
At March 31, 2020
|
10,798,106
|
4,456
|
10,071,706
|
20,874,268
|
(c.1)
Investments reserve
From net
income after deductions, the amount not exceeding 60% of the adjusted net income
is allocated to the investment reserve to support future investments.
(c.2)
Statutory reserve
From net
income, 5% will be applied before any other allocation to the statutory reserve,
which cannot exceed 20% of capital stock. The Company is not required to
supplement the statutory reserve in the year when the balance of this reserve,
plus the amount of capital reserves, exceeds 30% of the capital stock.
(c.3) Tax
incentives
The Company
has tax incentives framed in certain state and federal industrial-development
programs in the form of financing, deferred payment of taxes or partial
reductions of the
28
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
amount due. These programs aim to promote the expansion of employment generation, regional decentralization, complement and diversify the industrial base of the states. In these states, the grace periods, enjoyment and reductions are permitted under the tax law.
The portion of income for the period related to tax incentives, which will be allocated to the profit reserve at the end of the fiscal year on December 31, 2020 and therefore not being used as a basis for dividend distribution, was composed of:
|
03/31/2020
|
03/31/2019
|
ICMS (brazilian state value-added tax)
|
404,985
|
487,186
|
Income tax
|
15,136
|
41,700
|
|
420,121
|
528,886
|
(c.4) Interest on shareholders’ equity and dividends
Brazilian companies are permitted to distribute interest attributed to shareholders’ equity calculated based on the long-term interest rate (TJLP); this interest is tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.
As determined by its by-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending on December 31, an amount not less than 40% of its net income determined under Brazilian law, as adjusted in accordance with applicable law, unless payment of such amount would be incompatible with Ambev’s financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity.
There was no payment of dividends or interest on shareholders' equity in the three-month period ended March 31, 2020.
29
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(d) Carrying-value adjustments
|
Carrying value
adjustments
|
|
Translation
reserves
|
Cash flow
hedge
|
Actuarial gains/
(losses)
|
Options granted on
subsidiary
|
Gains/(losses) of
non-controlling interest´s share
|
Business
combination
|
Accounting
adjustments for transactions between shareholders
|
Total
|
At December 31, 2018
|
4,089,221
|
777,123
|
(1,116,114)
|
(120,083)
|
19,558
|
156,091
|
(75,390,552)
|
(71,584,756)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
Gains/(losses) on
translation of foreign operations
|
(198,902)
|
-
|
-
|
-
|
-
|
-
|
-
|
(198,902)
|
Cash flow hedges
|
-
|
(14,824)
|
-
|
-
|
-
|
-
|
-
|
(14,824)
|
Actuarial gains/(losses)
|
-
|
-
|
3,095
|
-
|
-
|
-
|
-
|
3,095
|
Total Comprehensive income
|
(198,902)
|
(14,824)
|
3,095
|
-
|
-
|
-
|
-
|
(210,631)
|
At March 31, 2019
|
3,890,319
|
762,299
|
(1,113,019)
|
(120,083)
|
19,558
|
156,091
|
(75,390,552)
|
(71,795,387)
|
|
Carrying value
adjustments
|
|
Translation
reserves
|
Cash flow
hedge
|
Actuarial gains/
(losses)
|
Options granted on
subsidiary
|
Gains/(losses) of
non-controlling interest´s share
|
Business
combination
|
Accounting
adjustments for transactions between shareholders
|
Total
|
At December 31, 2019
|
3,583,386
|
644,965
|
(1,220,882)
|
(120,083)
|
84,434
|
156,091
|
(75,402,375)
|
(72,274,464)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
Gains/(losses) on
translation of foreign operations
|
7,103,805
|
-
|
-
|
-
|
-
|
-
|
-
|
7,103,805
|
Cash flow hedges
|
-
|
543,944
|
-
|
-
|
-
|
-
|
-
|
543,944
|
Actuarial gains/(losses)
|
-
|
-
|
(4,698)
|
-
|
-
|
-
|
-
|
(4,698)
|
Total Comprehensive income
|
7,103,805
|
543,944
|
(4,698)
|
-
|
-
|
-
|
-
|
7,643,051
|
Options granted on subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Gains/(losses) of controlling interest´s
share
|
-
|
-
|
-
|
-
|
(756)
|
-
|
-
|
(756)
|
Tax on deemed dividends
|
-
|
-
|
-
|
-
|
(772)
|
-
|
-
|
(772)
|
At March 31, 2020
|
10,687,191
|
1,188,909
|
(1,225,580)
|
(120,083)
|
82,906
|
156,091
|
(75,402,375)
|
(64,632,941)
|
30
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(d.1) Translation reserves
The
translation reserves comprise all foreign currency exchange differences arising
from the translation of the interim financial statements with functional
currency different from the Real.
The
translation reserves also comprise the portion of the gain or loss on the
foreign currency liabilities and on the derivative financial instruments
determined to be effective net investment hedges.
(d.2) Cash flow hedge reserves
The hedging
reserves comprise the effective portion of the cumulative net change in the fair
value of cash flow hedges to the extent the hedged risk has not yet impacted
profit or loss (For additional information, see Note 21 – Financial instruments and risks).
(d.3)
Actuarial gains and losses
The actuarial
gains and losses include expectations with regards to future pension plan
obligations. Consequently, the results of actuarial gains and losses are
recognized on timely basis considering best estimate obtained by Management.
Accordingly, the Company recognizes on a monthly basis the results of these
estimated actuarial gains and losses based on the expectations presented in the
independent actuarial report.
The actuarial
gain of R$95.6 arising from the surplus reverted to the Sponsor (originating
from Ambev Private Pension Institute) from the defined benefits plan was fully
recorded under Actuarial gains and losses.
(d.4) Options
granted on subsidiary
As part of the
agreement to acquire the shares of Tenedora, CND S.A. (“Tenedora”) an option to
sell (“put”) was issued by Ambev in favor of ELJ and an option to purchase
(“call”) was issued from ELJ in favor of Ambev, which may result in an
acquisition by Ambev of the remaining shares of Tenedora, for a value based on
EBITDA, discounted of net debt, from operations, with a put exercisable at any
time. On January 18, 2018, ELJ partially exercised its put option related to
approximately 30% of capital stock by Tenedora. As a result, the Company became
the owner of approximately 85% of Tenedora. Additionally, it was approved to
change the call-option term from 2019 to 2022.
On March 31,
2020 the put option held by ELJ was valued at R$3,451,643 (R$2,950,489 on
December 31, 2019) and the liability categorized as “Level 3”, as under Note 21
(b) and in accordance with the IFRS 3. The fair value of this consideration
deferred was calculated by using standard valuation techniques
(present
31
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
value of the principal amount and future interest rates, discounted by the market rate). The criteria used are based on market information and from reliable sources and the fair value is revaluated on an annual basis.
As part of the agreement to acquire the shares of Sucos do Bem, the Company has been granted a put option and a call option on minority shareholders' participation determined by gross revenue of its products and exercisable until 2020, with a few exceptions. On March 31, 2020 the put option was valued at R$68,190 (R$68,252 on December 31, 2019).
The reconciliation of changes in these options is presented in Note 21 – Financial instruments and risks.
(d.5) Accounting for acquisition of non-controlling interests
Transactions with non-controlling interests of the same business, even when performed at arm's length, that present valid economic grounds and reflect normal market conditions, will be consolidated by the same applicable accounting standards as are used within the same accounting entity.
As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of non-controlling interests and are related to carrying amount of such non-controlling interest shall be recognized directly in controlling shareholders’ equity. The acquisition of non-controlling interest related to Old Ambev, the above-mentioned adjustment was recognized in the carrying value adjustments when applicable, due to the adoption of the predecessor basis of accounting.
32
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
14. SEGMENT
REPORTING
(a) Reportable
segments – Three-month period ended in:
|
Brazil
|
CAC
(i)
|
Latin America - South
(ii)
|
Canada
|
Consolidated
|
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
6,525,145
|
7,214,372
|
1,424,426
|
1,462,125
|
3,120,181
|
2,670,164
|
1,532,845
|
1,293,465
|
12,602,597
|
12,640,126
|
Cost of sales
|
(2,950,072)
|
(3,057,584)
|
(678,366)
|
(643,329)
|
(1,414,620)
|
(953,610)
|
(600,131)
|
(453,178)
|
(5,643,189)
|
(5,107,701)
|
Gross profit
|
3,575,073
|
4,156,788
|
746,060
|
818,796
|
1,705,561
|
1,716,554
|
932,714
|
840,287
|
6,959,408
|
7,532,425
|
Distribution expenses
|
(1,018,005)
|
(947,643)
|
(153,968)
|
(147,877)
|
(366,246)
|
(272,826)
|
(313,094)
|
(258,376)
|
(1,851,313)
|
(1,626,722)
|
Sales and marketing expenses
|
(827,626)
|
(767,306)
|
(150,935)
|
(138,319)
|
(323,389)
|
(283,575)
|
(253,589)
|
(212,081)
|
(1,555,539)
|
(1,401,281)
|
Administrative expenses
|
(406,607)
|
(382,298)
|
(51,190)
|
(70,860)
|
(120,796)
|
(120,358)
|
(86,753)
|
(88,006)
|
(665,346)
|
(661,522)
|
Other operating income/(expenses)
|
162,468
|
233,390
|
5,320
|
4,700
|
16,650
|
38
|
(13,169)
|
(6,875)
|
171,269
|
231,253
|
Exceptional items
|
(12,387)
|
(7,423)
|
(3,781)
|
(2,610)
|
(4,933)
|
(8,387)
|
(2,974)
|
-
|
(24,075)
|
(18,420)
|
Income from operations (EBIT)
|
1,472,916
|
2,285,508
|
391,506
|
463,830
|
906,847
|
1,031,446
|
263,135
|
274,949
|
3,034,404
|
4,055,733
|
Net finance cost
|
(1,069,031)
|
(322,850)
|
121,582
|
(16,652)
|
(558,555)
|
(306,470)
|
(30,863)
|
(26,096)
|
(1,536,867)
|
(672,068)
|
Share of result of joint
ventures
|
(1,660)
|
(934)
|
212
|
(1,490)
|
-
|
-
|
(5,169)
|
288
|
(6,617)
|
(2,136)
|
Income before income tax
|
402,225
|
1,961,724
|
513,300
|
445,688
|
348,292
|
724,976
|
227,103
|
249,141
|
1,490,920
|
3,381,529
|
Income tax expense
|
56,000
|
(69,801)
|
(119,722)
|
(164,804)
|
(106,322)
|
(282,972)
|
(109,624)
|
(114,884)
|
(279,668)
|
(632,461)
|
Net income
|
458,225
|
1,891,923
|
393,578
|
280,884
|
241,970
|
442,004
|
117,479
|
134,257
|
1,211,252
|
2,749,068
|
|
|
|
|
|
|
|
|
|
|
|
Normalized EBITDA (iii)
|
2,178,017
|
2,941,808
|
523,107
|
578,113
|
1,168,978
|
1,271,719
|
362,389
|
329,011
|
4,232,491
|
5,120,651
|
Exceptional items
|
(12,387)
|
(7,423)
|
(3,781)
|
(2,610)
|
(4,933)
|
(8,387)
|
(2,974)
|
-
|
(24,075)
|
(18,420)
|
Depreciation. amortization and
impairment
|
(692,714)
|
(648,877)
|
(127,820)
|
(111,673)
|
(257,198)
|
(231,886)
|
(96,280)
|
(54,062)
|
(1,174,012)
|
(1,046,498)
|
Net finance cost
|
(1,069,031)
|
(322,850)
|
121,582
|
(16,652)
|
(558,555)
|
(306,470)
|
(30,863)
|
(26,096)
|
(1,536,867)
|
(672,068)
|
Share of result of joint
ventures
|
(1,660)
|
(934)
|
212
|
(1,490)
|
-
|
-
|
(5,169)
|
288
|
(6,617)
|
(2,136)
|
Income tax expense
|
56,000
|
(69,801)
|
(119,722)
|
(164,804)
|
(106,322)
|
(282,972)
|
(109,624)
|
(114,884)
|
(279,668)
|
(632,461)
|
Net income
|
458,225
|
1,891,923
|
393,578
|
280,884
|
241,970
|
442,004
|
117,479
|
134,257
|
1,211,252
|
2,749,068
|
|
|
|
|
|
|
|
|
|
|
|
Normalized EBITDA margin in %
|
33.4%
|
40.8%
|
36.7%
|
39.5%
|
37.5%
|
47.6%
|
23.6%
|
25.4%
|
33.6%
|
40.5%
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of property, plant and
equipment
|
1,104,508
|
313,300
|
109,240
|
118,341
|
101,412
|
85,607
|
31,159
|
28,808
|
1,346,319
|
546,056
|
33
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(continued)
|
Brazil
|
CAC
(i)
|
Latin America - South
(ii)
|
Canada
|
Consolidated
|
|
03/31/2020
|
12/31/2019
|
03/31/2020
|
12/31/2019
|
03/31/2020
|
12/31/2019
|
03/31/2020
|
12/31/2019
|
03/31/2020
|
12/31/2019
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets
|
44,290,663
|
44,161,917
|
14,440,482
|
11,393,314
|
17,576,904
|
14,453,984
|
14,965,504
|
12,034,975
|
91,273,553
|
82,044,190
|
Intersegment elimination
|
|
|
|
|
|
|
|
|
(2,383,346)
|
(2,286,215)
|
Non-segmented assets
|
|
|
|
|
|
|
|
|
24,797,354
|
21,984,969
|
Total assets
|
|
|
|
|
|
|
|
|
113,687,561
|
101,742,944
|
|
|
|
|
|
|
|
|
|
|
|
Segment liabilities
|
19,511,136
|
19,907,373
|
4,293,000
|
3,932,812
|
4,756,847
|
4,411,757
|
4,872,578
|
4,078,743
|
33,433,561
|
32,330,685
|
Intersegment elimination
|
|
|
|
|
|
|
|
|
(2,383,257)
|
(2,286,406)
|
Non-segmented liabilities
|
|
|
|
|
|
|
|
|
82,637,257
|
71,698,665
|
Total liabilities
|
|
|
|
|
|
|
|
|
113,687,561
|
101,742,944
|
(i) CAC: includes operations in
Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El
Salvador, Nicaragua, Honduras, Barbados and Panama.
(ii) Latin America – South:
includes operations in Argentina, Bolivia, Chile, Paraguay and
Uruguay.
(iii) Normalized EBITDA is
calculated excluding of the net income the following effects: (i) income tax
expense, (ii) share of results of joint ventures (iii) net finance result, (iv)
exceptional items, and (v) depreciation, amortization and impairment of
property, plant and equipment.
34
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
(b)
Additional information – by Business unit – Three-month period ended
in:
|
Brazil
|
|
Beer
|
Soft drink and
Non-alcoholic and
non-carbonated
|
Total
|
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
03/31/2020
|
03/31/2019
|
|
|
|
|
|
|
|
Net sales
|
5,454,627
|
6,132,821
|
1,070,518
|
1,081,551
|
6,525,145
|
7,214,372
|
Cost of sales
|
(2,401,356)
|
(2,498,233)
|
(548,716)
|
(559,351)
|
(2,950,072)
|
(3,057,584)
|
Gross profit
|
3,053,271
|
3,634,588
|
521,802
|
522,200
|
3,575,073
|
4,156,788
|
Distribution expenses
|
(824,826)
|
(778,128)
|
(193,179)
|
(169,515)
|
(1,018,005)
|
(947,643)
|
Sales and marketing expenses
|
(747,281)
|
(696,203)
|
(80,345)
|
(71,103)
|
(827,626)
|
(767,306)
|
Administrative expenses
|
(348,030)
|
(328,326)
|
(58,577)
|
(53,972)
|
(406,607)
|
(382,298)
|
Other operating income/(expenses)
|
130,853
|
175,564
|
31,615
|
57,826
|
162,468
|
233,390
|
Exceptional items
|
(12,387)
|
(6,289)
|
-
|
(1,134)
|
(12,387)
|
(7,423)
|
Income from operations (EBIT)
|
1,251,600
|
2,001,206
|
221,316
|
284,302
|
1,472,916
|
2,285,508
|
Net finance cost
|
(1,069,031)
|
(316,499)
|
-
|
(6,351)
|
(1,069,031)
|
(322,850)
|
Share of result of joint
ventures
|
(1,660)
|
(934)
|
-
|
-
|
(1,660)
|
(934)
|
Income before income tax
|
180,909
|
1,683,773
|
221,316
|
277,951
|
402,225
|
1,961,724
|
Income tax expense
|
56,000
|
(69,801)
|
-
|
-
|
56,000
|
(69,801)
|
Net income
|
236,909
|
1,613,972
|
221,316
|
277,951
|
458,225
|
1,891,923
|
|
|
|
|
|
|
|
Normalized EBITDA (i)
|
1,866,250
|
2,578,155
|
311,767
|
363,653
|
2,178,017
|
2,941,808
|
Exceptional items
|
(12,387)
|
(6,289)
|
-
|
(1,134)
|
(12,387)
|
(7,423)
|
Depreciation, amortization and
impairment
|
(602,263)
|
(570,660)
|
(90,451)
|
(78,217)
|
(692,714)
|
(648,877)
|
Net finance cost
|
(1,069,031)
|
(316,499)
|
-
|
(6,351)
|
(1,069,031)
|
(322,850)
|
Share of result of joint
ventures
|
(1,660)
|
(934)
|
-
|
-
|
(1,660)
|
(934)
|
Income tax expense
|
56,000
|
(69,801)
|
-
|
-
|
56,000
|
(69,801)
|
Net income
|
236,909
|
1,613,972
|
221,316
|
277,951
|
458,225
|
1,891,923
|
|
|
|
|
|
|
|
Normalized EBITDA margin in %
|
34.2%
|
42.0%
|
29.1%
|
33.6%
|
33.4%
|
40.8%
|
35
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
15. NET SALES
Reconciliation between gross sales and net sales:
|
03/31/2020
|
03/31/2019
|
|
|
|
Gross sales and/or services
|
18,742,618
|
18,769,815
|
Excise duty
|
(3,939,979)
|
(4,097,407)
|
Discounts
|
(2,200,042)
|
(2,032,282)
|
|
12,602,597
|
12,640,126
|
Services provided by distributors, such as the promotion of our brands and logistics services, are considered as expenses when separately identifiable.
16. OTHER OPERATING INCOME / (EXPENSES)
|
03/31/2020
|
03/31/2019
|
Government grants/NPV of long-term fiscal incentives
|
156,556
|
204,097
|
(Additions)/reversals of provisions
|
(2,550)
|
2,760
|
Gains/(losses) on disposal of property, plant and equipment, intangible assets and operation of associates
|
15,951
|
2,668
|
Other operating income/(expenses), net
|
1,312
|
21,728
|
|
171,269
|
231,253
|
Government grants are not recognized until there is reasonable assurance that the Company will meet related conditions and that the grants will be received. Government grants are systematically recognized in income during the periods in which the Company recognizes as expenses the related costs that the grants are intended to offset.
17. EXCEPTIONAL ITEMS
|
03/31/2020
|
03/31/2019
|
Restructuring (i)
|
(13,880)
|
(18,211)
|
Effect of application of IAS 29 (hyperinflation)
|
-
|
(209)
|
COVID-19 impacts (ii)
|
(10,195)
|
-
|
|
(24,075)
|
(18,420)
|
|
|
|
(i) The restructuring expenses recognized refer mainly to the realignment of the structures and processes in the Latin America geographical segment, CAC and Brazil.
(ii) Covid-19 expenses refer to additional expenses to ensure the safety of our people - additional expenses with alcohol in gel, masks and additional cleaning at our facilities and donations realized to others institutions.
36
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
18. FINANCE
EXPENSES AND INCOME
(a) Finance
expenses
|
03/31/2020
|
03/31/2019
|
Interest expense
|
(426,471)
|
(391,297)
|
Capitalized borrowings
|
-
|
-
|
Net Interest on pension
plans
|
(25,563)
|
(25,092)
|
Losses on hedging instruments and
exclusive investment funds
|
(945,408)
|
(194,929)
|
Interest on provision for disputes and
litigations
|
(16,274)
|
(16,366)
|
Exchange variation
|
(195,622)
|
(125,560)
|
Interest and foreign exchange rate on
loans
|
(8,608)
|
(21,684)
|
Financial instruments at fair value through profit
or loss
|
(2,133)
|
-
|
Tax on financial transactions
|
(86,603)
|
(53,933)
|
Bank guarantee expenses
|
(35,834)
|
(28,328)
|
Other financial results
|
(40,127)
|
(102,572)
|
|
(1,782,643)
|
(959,761)
|
Interest
expenses are presented net of the effect of interest rate derivative financial
instruments which mitigate Ambev’s interest rate risk (Note 21 – Financial instruments and risks).
The interest expenses were as follows:
|
03/31/2020
|
03/31/2019
|
Financial instruments measured at amortized
cost
|
(116,103)
|
(127,193)
|
Financial instruments at fair value through profit
or loss
|
(310,368)
|
(264,104)
|
|
(426,471)
|
(391,297)
|
(b) Finance
income
|
03/31/2020
|
03/31/2019
|
Interest income
|
147,575
|
135,270
|
Financial instruments at fair value
through profit or loss
|
-
|
36,410
|
Other financial results
|
18,060
|
19,301
|
|
165,635
|
190,981
|
|
|
|
Effect of application of IAS 29
(hyperinflation)
|
80,141
|
96,712
|
|
245,776
|
287,693
|
Interest
income arose from the following financial assets:
|
03/31/2020
|
03/31/2019
|
Cash and cash equivalents
|
84,000
|
96,132
|
Investment securities held for
trading
|
124
|
4,133
|
Other receivables
|
63,451
|
35,005
|
|
147,575
|
135,270
|
37
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
19. INCOME TAX AND
SOCIAL CONTRIBUTION
Income taxes
reported in the income statement were as follows:
|
03/31/2020
|
03/31/2019
|
Income tax expense - current
|
(295,033)
|
(979,185)
|
|
|
|
Deferred tax expense on temporary
differences
|
(128,782)
|
345,151
|
Deferred tax over taxes losses
carryforwards movements in the current period
|
144,147
|
1,573
|
Total deferred tax
(expense)/income
|
15,365
|
346,724
|
|
|
|
Total income tax expenses
|
(279,668)
|
(632,461)
|
The
reconciliation from the weighted nominal to the effective tax rate is summarized
as follows:
|
03/31/2020
|
03/31/2019
|
Profit before tax
|
1,490,920
|
3,381,529
|
Adjustment on taxable basis
|
|
|
Others non-taxable income
|
(254,422)
|
(66,978)
|
Government grants related to sales
taxes
|
(404,985)
|
(487,186)
|
Share of result of joint
ventures
|
6,617
|
2,136
|
Non-deductible expenses
|
56,212
|
67,990
|
Complement of income tax of foreign
subsidiaries due in Brazil
|
52,767
|
122,668
|
Results of intercompany transactions
|
-
|
57,281
|
|
947,109
|
3,077,440
|
Aggregated weighted nominal tax
rate
|
28.74%
|
29.59%
|
Taxes payable – nominal rate
|
(272,222)
|
(910,584)
|
Adjustment on tax expense
|
|
|
Income tax incentives
|
15,136
|
41,700
|
Deductible interest on shareholders'
equity
|
141,389
|
369,036
|
Tax savings from goodwill
amortization
|
19,366
|
22,452
|
Withholding income tax
|
(241,628)
|
(65,109)
|
Recognition/(write-off) of deferred
charges on tax losses
|
(46,070)
|
(30,232)
|
Effect of application of IAS 29
(hyperinflation)
|
(19,553)
|
(18,246)
|
Others with reduced taxation
|
123,914
|
(41,478)
|
Income tax and social contribution
expense
|
(279,668)
|
(632,461)
|
Effective tax rate
|
18.76%
|
18.70%
|
The main
events that impacted the effective tax rate in the period were:
§
Government subsidy on sales taxes: Related to regional incentives and local production,
which, when reinvested, are not taxed for income tax and social contribution
purposes; this explains the impact on the effective tax rate. The amount
above is impacted by the fluctuation in volume, price and eventual variation on
state VAT (ICMS).
38
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
§
Complement of income tax of foreign subsidiaries due in
Brazil: shows the result of the calculation of universal taxation of profits,
according to the regulations of Law 12.973/14.
§
Withholding income tax: The amount is mainly related to
dividends distributed and to be distributed by subsidiaries located outside of
Brazil, applicable according to local tax legislation. The increase in the
amount in 2020 is mainly due to the exchange rate variation of the balances held
in liabilities
§
Deductible interest on shareholders’ equity: under
Brazilian law, companies have an option to remunerate their shareholders through
payment of interest on capital (“IOC”), which is deductible for income tax
purposes.
20. SHARE-BASED
PAYMENTS
There are
different stock-option and share-based payment programs which allow the
employees and senior Management from the Company and its subsidiaries to acquire
(through of exercise of the stock option) or receive shares of the Company. For
all stock option programs, the fair value of the shares is estimated at the
options grant date, using the “Hull Binomial” pricing model, adjusted to reflect
the IFRS 2 requirement that assumptions about forfeiture before the end of the
vesting period cannot impact the fair value of the option.
This current
model of stock option, ruled by the Company’s stock option plan (“Stock Option
Plan”), includes two types of grants: (I) Grant 1- the beneficiary can be
allocated 30%, 40%, 60%, 70% or 100% of the amount related to the profit share
the beneficiary received in the year, to the immediate exercise of options, thus
acquiring the corresponding shares of the Company, which transfer to third
parties or the Company will only be allowed after the five-year period
counted from the date of exercise of the options; and (II) Grant 2 - the
beneficiary may exercise the options after a five-year grace period, for a
period of five years.
In addition,
the Company has implemented a share-based compensation plan (“Share-Based Plan”)
under which certain employees and members of the Management of the Company or
its subsidiaries are eligible to receive shares of the Company including in the
form of ADRs. The shares that are subject to the Share-Based Plan are designated
as "restricted shares".
Additionally,
as a mean of creating a long term incentive (wealth incentive) for certain
senior employees and members of Management considered as having “high
potential,” the Company grants, under the Share-Based Plan, shares to be
delivered in the future divided in two separate lots – Lot A and Lot B, which
will be delivered to the
39
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
participants of the relevant program, subject to maturation periods of five and ten years, respectively.
The weighted average fair value of the options and assumptions used in applying the Company’s option pricing model of 2020 and 2019 grants was as follows:
In R$, except when otherwise indicated
|
03/31/2020
|
(i)
|
12/31/2019
|
(i)
|
|
|
|
|
|
Fair value of options granted
|
4.04
|
|
4.50
|
|
Share price
|
18.05
|
|
17.66
|
|
Exercise price
|
18.05
|
|
17.66
|
|
Expected volatility
|
22.3%
|
|
23.8%
|
|
Vesting year
|
5
|
|
5
|
|
Expected dividends
|
5%
|
|
5%
|
|
Risk-free interest rate
|
6.8%
|
(ii)
|
7.8%
|
(ii)
|
(i) Information based on weighted average plans granted, except for the expected dividends and risk-free interest rate.
(ii) The percentages include the grants of stock options and ADRs during the period, in which the risk-free interest rate of ADRs are calculated in U.S. dollar.
The total number of outstanding options developed was as follows:
Thousand options
|
03/31/2020
|
|
12/31/2019
|
|
|
|
|
Options outstanding at January 1st
|
141,736
|
|
141,328
|
Options issued during the period
|
22
|
|
24,593
|
Options exercised during the period
|
(2,703)
|
|
(7,849)
|
Options forfeited during the period
|
(1,834)
|
|
(16,336)
|
Options outstanding at ended period
|
137,221
|
|
141,736
|
The range of exercise prices of the outstanding options was between R$9.36 (R$0.001 on December 31, 2019) and R$36.34 (R$34.37 on December 31, 2019) and the weighted average remaining contractual life was approximately 6.20 years (6.33 years on December 31, 2019).
Of the 137,221 thousand outstanding options (141,736 thousand on December 31, 2019), 43,196 thousand options were vested on March 31, 2020 (46,640 thousand on December 31, 2019).
The weighted average exercise price of the options was as follows:
In R$ per share
|
03/31/2020
|
|
12/31/2019
|
|
|
|
|
Options outstanding at January 1 st
|
18.53
|
|
16.16
|
Options issued during the period
|
18.05
|
|
18.05
|
Options forfeited during the period
|
19.54
|
|
21.24
|
Options exercised during the period
|
6.67
|
|
9.07
|
Options outstanding at the end of the period
|
19.02
|
|
18.53
|
Options exercisable at the end of the period
|
20.70
|
|
19.12
|
40
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
For the
options exercised during the period ended March 31, 2020, the weighted average
share price on the exercise date was R$15.84 (R$18.68 as of December 31,
2019).
To settle the
exercised stock options, the Company may use treasury shares. The current limit
of authorized capital is considered sufficient to meet all stock option plans if
the issue of new shares is required to meet the grants awarded in the
programs.
During the
period, the Company did not grant deferred stocks under the stock option plan
(as at December 2019, 208 thousand deferred stocks had been granted related to
the exercise of stock options granted in the previous years, and such
shares were valued based on the share price of the trading session immediately
prior to the stock option grant, representing a fair value of R$3,787 on
December 31, 2019). Such deferred stock options are subject to a vesting period
of five years from the date of their grant.
During the
period, the Company granted 1,565,000 (11,838,000 as at December 31, 2019)
restricted shares under the Share-Based Plan, which are valued based on the
share price of the trading session immediately prior to the grant of shares,
representing a fair value of approximately R$28,866 on March 31, 2020 (R$211,728
as at December 31, 2019). Such restricted share units are subject to a grace
period of five years counted from the date of the grant.
The total
number of shares purchased or granted, according to each category, under the Stock Option Plan
and Share-Based Plan by employees is demonstrated below; the grant of these
shares will be performed in the future under certain conditions (deferred stock
and restricted shares).
Thousand deferred shares
|
03/31/2020
|
|
12/31/2019
|
|
|
|
|
Deferred shares outstanding at January
1st
|
7,926
|
|
12,308
|
New deferred shares during the period
|
-
|
|
208
|
Deferred shares granted during the
period
|
(1,543)
|
|
(4,167)
|
Deferred shares forfeited during the
period
|
(69)
|
|
(423)
|
Deferred shares outstanding at at the
end of the period
|
6,314
|
|
7,926
|
Thousand restricted shares
|
03/31/2020
|
|
12/31/2019
|
|
|
|
|
Restricted shares outstanding at
January 1st
|
23,836
|
|
12,656
|
New restricted shares during the
period
|
1,565
|
|
11,838
|
Restricted shares granted during the
period
|
-
|
|
-
|
Restricted shares forfeited during the
period
|
(105)
|
|
(658)
|
Restricted shares outstanding at the
end of the period
|
25,296
|
|
23,836
|
41
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
Additionally, certain employees and managers of the Company received options to acquire AB Inbev shares, the compensation cost of which is recognized in the income statement against equity.
The transactions with share-based payments described above generated an expense of R$37,697 on March 31, 2020 (R$50,266 on March 31, 2019), recorded as administrative expenses.
21. FINANCIAL INSTRUMENTS AND RISKS
Risk factors
The Company is exposed to foreign currency, interest rate, commodity price, liquidity and credit risk in the ordinary course of business. The Company analyzes each of these risks both individually and to define strategies to manage the economic impact on Company’s performance consistent with its Financial Risk Management Policy.
The Company’s use of derivatives strictly follows the Financial Risk Management Policy approved by the Board of Directors. The purpose of the policy is to provide guidelines for the management of financial risks inherent to the capital markets in which Ambev carries out its operations. The policy comprises four main aspects: (i) capital structure, financing and liquidity, (ii) transactional risks related to the business, (iii) financial statements translation risks and (iv) credit risks of financial counterparties.
The policy establishes that all the financial assets and liabilities in each country where Ambev operates must be denominated in their respective local currencies. The policy also sets forth the procedures and controls needed for identifying, measuring and minimizing market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, wheat, corn and sugar) that may affect Ambev’s revenues, costs and/or investment amounts. The policy states that all the known risks (e.g. foreign currency and interest) will be hedged by contracting derivative financial instruments. Existing risks not yet recorded (e.g. future contracts for the purchase of raw material or property, plant and equipment) are mitigated using projections for the period necessary for the Company to adapt to the new cost scenario, which may vary from ten to fourteen months, also through the use of derivative financial instruments. Most of the translation risks are not hedged. Any exception to the policy must be approved by the Board of Directors.
Derivative financial instruments
Derivative financial instruments authorized by the Financial Risk Management Policy are futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps and options. At March 31, 2020, the Company and its subsidiaries had no target forward, swaps with currency verification or any other derivative
42
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
operations representing a risk level above the nominal value of their contracts. The derivative operations are managed on a consolidated basis and are classified by strategies according to their purposes, as follows:
i) Cash-flow-hedge derivative instruments – The highly probable forecast transactions contracted in order to minimize the Company's exposure to fluctuations of exchange rates and prices of raw materials, investments, equipment and services to be procured, are protected by cash flow hedges that will occur at various different dates during the next fourteen months. Gains and losses classified as hedging reserve in equity are recognized in the income statement in the period or periods when the forecast and hedged transaction affects the income statement.
ii) Fair-value-hedge derivative instruments – operations contracted with the purpose of mitigating the Company’s net indebtedness against foreign exchange and interest rate risk. Cash net positions and foreign currency debts are continually assessed for identification of new exposures.
The results of these operations, measured according to their fair value, are recognized in financial results.
iii) Net-investment-hedge derivative instruments – transactions entered into in order to minimize exposure of the exchange differences arising from conversion of net investment in the Company's subsidiaries located abroad for translation account balance. The effective portion of the hedge is allocated to equity and the ineffectiveness portion is recorded directly in financial results.
The following tables summarize the exposure of the Company that were identified and protected in accordance with the Company's Risk Policy. The following denominations have been applied:
Operational Hedge: Refers to the exposures arising from the core business of Ambev, such as purchase of inputs, purchase of fixed assets and service contracts linked to foreign currency, which is protected through the use of derivatives.
Financial Hedge: Refers to the exposures arising from cash and financing activities, such as foreign-currency cash and foreign-currency debt, which is protected through the use of derivatives.
Investment hedge abroad: Refers mainly to exposures arising from cash held in foreign currency in foreign subsidiaries whose functional currency is different from the consolidation currency.
Investment hedge - Put option granted on subsidiary: As detailed in Note 13 (d.4) the Company constituted a liability related to acquisition of a non-controlling interest in the Dominican Republic operations. This financial instrument is denominated in
43
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
Dominican Pesos and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for part of its net assets located in the Dominican Republic, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.
44
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Transactions
protected by derivative financial instruments in accordance with the Financial
Risk Management Policy
|
|
|
|
|
|
|
03/31/2020
|
|
03/31/2020
|
|
|
|
|
|
|
|
Fair Value
|
|
Gain /
(Losses)
|
Exposure
|
|
Risk
|
|
|
Notional
|
|
Assets
|
Liability
|
|
Finance
Result
|
Operational Result
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
(12,948,715)
|
|
12,699,177
|
|
355,677
|
(639,404)
|
|
(288,837)
|
314,270
|
1,132,072
|
|
|
Commodity
|
(3,190,728)
|
|
2,941,190
|
|
1,726
|
(537,729)
|
|
(30,129)
|
(20,212)
|
(334,933)
|
|
|
American Dollar
|
(9,355,590)
|
|
9,355,590
|
|
307,502
|
(83,244)
|
|
(260,461)
|
353,600
|
1,455,510
|
|
|
Euro
|
(196,537)
|
|
196,537
|
|
8,747
|
-
|
|
(1,923)
|
(521)
|
13,108
|
|
|
Mexican Pesos
|
(205,860)
|
|
205,860
|
|
37,702
|
(18,431)
|
|
3,676
|
(18,597)
|
(1,613)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Assets
|
|
|
(986,209)
|
|
986,209
|
|
10,360
|
(18,449)
|
|
(98,847)
|
32,031
|
36,645
|
|
|
American Dollar
|
(986,209)
|
|
986,209
|
|
10,360
|
(18,449)
|
|
(98,847)
|
32,031
|
36,645
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
(287,900)
|
|
287,900
|
|
5,043
|
(4,307)
|
|
(481)
|
474
|
178
|
|
|
American Dollar
|
(287,900)
|
|
287,900
|
|
5,043
|
(4,307)
|
|
(481)
|
474
|
178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debts
|
|
|
(389,891)
|
|
-
|
|
-
|
-
|
|
-
|
-
|
-
|
|
|
American Dollar
|
(153,202)
|
|
-
|
|
-
|
-
|
|
-
|
-
|
-
|
|
|
Interest rate
|
(236,689)
|
|
-
|
|
-
|
-
|
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
|
(733,317)
|
|
1,181,084
|
|
669
|
(516,758)
|
|
(541,225)
|
-
|
-
|
|
|
Stock exchange prices
|
(733,317)
|
|
1,181,084
|
|
669
|
(516,758)
|
|
(541,225)
|
-
|
-
|
March 31, 2020
|
|
|
(15,346,032)
|
|
15,154,370
|
|
371,749
|
(1,178,918)
|
|
(929,390)
|
346,775
|
1,168,895
|
45
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
|
|
|
|
|
|
12/31/2019
|
|
03/31/2019
|
|
|
|
|
|
|
|
Fair Value
|
|
Gain /
(Losses)
|
Exposure
|
|
Risk
|
|
|
Notional
|
|
Assets
|
Liability
|
|
Finance
Result
|
Operational Result
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
(11,823,740)
|
|
11,630,267
|
|
122,211
|
(266,416)
|
|
(187,460)
|
385,151
|
292,620
|
|
|
Commodity
|
(2,293,500)
|
|
2,100,027
|
|
36,767
|
(74,796)
|
|
(10,777)
|
(14,658)
|
58,675
|
|
|
American Dollar
|
(9,192,368)
|
|
9,192,368
|
|
44,319
|
(188,568)
|
|
(174,867)
|
418,580
|
257,970
|
|
|
Euro
|
(177,565)
|
|
177,565
|
|
-
|
(3,052)
|
|
(969)
|
(1,639)
|
(5,661)
|
|
|
Mexican Pesos
|
(160,307)
|
|
160,307
|
|
41,125
|
-
|
|
(847)
|
(17,132)
|
(18,364)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Assets
|
|
|
(816,909)
|
|
816,909
|
|
11,394
|
(53,782)
|
|
(58,410)
|
52,516
|
74,779
|
|
|
American Dollar
|
(816,909)
|
|
816,909
|
|
11,394
|
(53,782)
|
|
(58,410)
|
52,516
|
74,779
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
(262,098)
|
|
262,098
|
|
2,229
|
(17,268)
|
|
(17,237)
|
1,125
|
21,964
|
|
|
American Dollar
|
(262,098)
|
|
262,098
|
|
2,229
|
(17,268)
|
|
(17,239)
|
1,283
|
22,070
|
|
|
Rupee
|
-
|
|
-
|
|
-
|
-
|
|
2
|
(158)
|
(106)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
|
-
|
|
-
|
|
-
|
-
|
|
(1)
|
-
|
-
|
|
|
Interest rate
|
-
|
|
-
|
|
-
|
-
|
|
(1)
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debts
|
|
|
(362,773)
|
|
-
|
|
-
|
-
|
|
624
|
-
|
-
|
|
|
American Dollar
|
(114,358)
|
|
-
|
|
-
|
-
|
|
-
|
-
|
-
|
|
|
Interest rate
|
(248,415)
|
|
-
|
|
-
|
-
|
|
624
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
|
(1,873,396)
|
|
1,057,829
|
|
37,534
|
(17,904)
|
|
79,056
|
-
|
-
|
|
|
Stock Exchange Prices
|
(1,873,396)
|
|
1,057,829
|
|
37,534
|
(17,904)
|
|
79,056
|
-
|
-
|
Total
|
|
|
(15,138,916)
|
|
13,767,103
|
|
173,368
|
(355,370)
|
|
(183,428)
|
438,792
|
389,363
|
46
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
I.
Market risk
a.1)
Foreign-currency risk
The Company is
exposed to foreign currency risk on borrowings, investments, purchases,
dividends and/or interest expense and income whenever they are denominated in a
currency other than the functional currency of the subsidiary. The main
derivatives financial instruments used to manage foreign currency risk are
futures contracts, swaps, options, non-deliverable forwards and full deliverable
forwards.
a.2) Commodity
risk
A significant
portion of the Company’s inputs comprise commodities which historically have
experienced substantial price fluctuations. The Company therefore uses both
fixed price purchasing contracts and derivative financial instruments to
minimize its exposure to commodity price volatility of aluminum, sugar, wheat
and corn. These derivative financial instruments have been designated as
cash-flow hedges.
a.3) Interest
rate risk
The Company
applies a dynamic interest rate hedging approach whereby the target mix between
fixed and floating rate debts is reviewed periodically with purpose of achieve
an optimal balance between cost of funding and volatility of financial results,
taking into account market conditions as well as the Company’s overall business
strategy and this strategy is reviewed periodically.
The table below demonstrates the
Company’s exposure related to debts, before and after interest rates hedging
strategy. In 2020, the Company is not applying hedge for the exposures described
below:
|
03/31/2020
|
|
Risk
|
|
Interest
rate
|
Amount
|
Brazilian Real
|
7.8%
|
2,352,236
|
Working capital in Argentinean peso
|
94.0%
|
-
|
Dominican Peso
|
10.0%
|
265,644
|
American Dollar
|
4.1%
|
31,270
|
Guatemala´s Quetzal
|
6.3%
|
15,253
|
Canadian Dollar
|
3.5%
|
324,650
|
Others
|
8.8%
|
200,250
|
Interest rate pre-set
|
|
3,189,303
|
|
|
|
|
|
|
Brazilian Real
|
9.3%
|
161,727
|
American Dollar
|
4.1%
|
121,931
|
Canadian Dollar
|
2.7%
|
489
|
Interest rate post fixed
|
|
284,147
|
47
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
12/31/2019
|
|
Pre -
Hedge
|
|
Interest
rate
|
Amount
|
Brazilian Real
|
10.4%
|
2,006,718
|
Working capital in Argentinean peso
|
94.0%
|
24
|
Dominican Peso
|
10.0%
|
209,737
|
American Dollar
|
4.7%
|
19,054
|
Guatemala´s Quetzal
|
6.3%
|
12,009
|
|
0.0%
|
-
|
Canadian Dollar
|
3.5%
|
243,738
|
Others
|
9.2%
|
126,252
|
Interest rate pre-set
|
|
2,617,532
|
|
|
|
|
|
|
Brazilian Real
|
9.3%
|
171,809
|
American Dollar
|
4.1%
|
95,304
|
Canadian Dollar
|
2.7%
|
472
|
Interest rate post fixed
|
|
267,585
|
Terms and debt repayment
schedule
|
|
|
|
|
|
03/31/2020
|
|
Carrying
amount
|
Less than 1
year
|
1-2 years
|
2-3 years
|
3-5 years
|
More than
5
years
|
Trade and other payables(i)
|
25,564,624
|
20,428,637
|
4,129,796
|
238,313
|
380,427
|
387,451
|
Secured bank loans
|
473,385
|
210,730
|
55,966
|
54,416
|
55,333
|
96,940
|
Unsecured bank loans
|
318,896
|
52,127
|
266,769
|
-
|
-
|
-
|
Debentures and Bonds
|
107,096
|
-
|
107,096
|
-
|
-
|
-
|
Unsecured other loans
|
140,087
|
38,629
|
35,876
|
31,099
|
4,466
|
30,017
|
Lease liabilities
|
2,433,986
|
478,604
|
729,723
|
288,980
|
420,168
|
516,511
|
|
29,038,074
|
21,208,727
|
5,325,226
|
612,808
|
860,394
|
1,030,919
|
|
|
|
|
|
|
03/31/2019
|
|
Carrying
amount
|
Less than 1
year
|
1-2 years
|
2-3 years
|
3-5 years
|
More than
5
years
|
Trade and other payables(i)
|
25,589,612
|
21,498,681
|
3,282,421
|
253,629
|
214,291
|
340,590
|
Secured bank loans
|
461,154
|
176,673
|
55,564
|
54,748
|
62,541
|
111,628
|
Unsecured bank loans
|
212,668
|
94
|
209,831
|
2,743
|
-
|
-
|
Debentures and Bonds
|
106,611
|
-
|
106,611
|
-
|
-
|
-
|
Unsecured other loans
|
134,466
|
40,378
|
34,725
|
31,277
|
5,725
|
22,361
|
Lease liabilities
|
2,147,905
|
436,004
|
485,275
|
367,675
|
317,349
|
541,602
|
|
28,652,416
|
22,151,830
|
4,174,427
|
710,072
|
599,906
|
1,016,181
|
(i) Includes mainly the amount of
suppliers, taxes, fees and contributions payables, dividends and interest on
equity payable, salaries and charges, put option related to our participation in
subsidiary and other liabilities, except for related parties.
Sensitivity
analysis
The Company
mitigates risks arising from non-derivative financial assets and liabilities
substantially, through derivative financial instruments. In this context, the
Company has identified the main risk factors that may generate losses from these
derivative financial instruments and has developed a sensitivity analysis based
on three scenarios, which may impact the Company’s future results and/or cash
flow, as described below:
48
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For
the period ended March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
1 – Probable
scenario: Management expectations of deterioration in each transaction’s main
risk factor. To measure the possible effects on the results of derivative
transactions, the Company uses parametric value at risk (VaR), which is a
statistical measure developed through estimates of standard deviation and
correlation between the returns of several risk factors. This model results in
the loss limit expected for an asset over a certain time period and confidence
interval. Under this methodology, we used the potential exposure of each
financial instrument, a range of 95% and horizon of 21 days after March 31, 2020
for the calculation, which are presented in the module.
2 – Adverse scenario: 25% deterioration in each
transaction’s main risk factor as compared to the level observed on March 31,
2020.
3 – Remote
scenario: 50% deterioration in each transaction’s main risk factor as compared
to the level observed on March 31, 2020.
Transaction
|
Risk
|
Fair Value
|
Probable
scenario
|
Adverse
scenario
|
Remote
scenario
|
|
|
|
|
|
|
Commodities hedge
|
Decrease on commodities price
|
(536,003)
|
(599,227)
|
(1,271,300)
|
(2,006,598)
|
Input purchase
|
|
536,003
|
606,684
|
1,333,685
|
2,131,367
|
Foreign exchange hedge
|
Foreign currency decrease
|
252,276
|
134,683
|
(2,187,221)
|
(4,626,718)
|
Input purchase
|
|
(252,276)
|
(134,683)
|
2,187,221
|
4,626,718
|
Costs effects
|
|
-
|
7,457
|
62,385
|
124,769
|
|
|
|
|
|
|
Foreign exchange hedge
|
Foreign currency decrease
|
(8,089)
|
(31,551)
|
(254,641)
|
(501,193)
|
Capex Purchase
|
|
8,089
|
31,551
|
254,641
|
501,193
|
Fixed assets effects
|
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
Foreign exchange hedge
|
Foreign currency decrease
|
736
|
(6,288)
|
(71,239)
|
(143,214)
|
Expenses
|
|
(736)
|
6,288
|
71,239
|
143,214
|
Expenses effects
|
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
Debt
|
Foreign currency decrease
|
-
|
1,187
|
38,300
|
76,601
|
Interest expenses
|
Increase in interest rate
|
-
|
1,548
|
15,217
|
28,633
|
Debt effects
|
|
-
|
2,735
|
53,517
|
105,234
|
|
|
|
|
|
|
Equity Instrument Hedge
|
Stock exchange price decrease
|
(516,089)
|
(578,277)
|
(811,360)
|
(1,106,631)
|
Expenses
|
|
516,089
|
556,708
|
699,418
|
882,748
|
Equity effects
|
|
-
|
(21,569)
|
(111,942)
|
(223,883)
|
|
|
-
|
(11,377)
|
3,960
|
6,120
|
As at March
31, 2020 the notional and fair value amounts per instrument and maturity were as
follows:
|
|
Notional Value
|
Exposure
|
Risk
|
2020
|
2021
|
2022
|
2023
|
>2023
|
Total
|
|
|
|
|
|
|
|
|
Cost
|
|
11,234,707
|
1,464,470
|
-
|
-
|
-
|
12,699,177
|
|
Commodity
|
2,226,998
|
714,192
|
-
|
-
|
-
|
2,941,190
|
|
American Dollar
|
8,709,802
|
645,788
|
-
|
-
|
-
|
9,355,590
|
|
Euro
|
174,461
|
22,076
|
-
|
-
|
-
|
196,537
|
|
Mexican Peso
|
123,446
|
82,414
|
-
|
-
|
-
|
205,860
|
|
|
|
|
|
|
|
|
Fixed asset
|
|
930,230
|
55,979
|
-
|
-
|
-
|
986,209
|
|
American Dollar
|
930,230
|
55,979
|
-
|
-
|
-
|
986,209
|
|
|
|
|
|
|
|
|
Expenses
|
|
272,919
|
14,981
|
-
|
-
|
-
|
287,900
|
|
American Dollar
|
272,919
|
14,981
|
-
|
-
|
-
|
287,900
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
1,181,084
|
-
|
-
|
-
|
-
|
1,181,084
|
|
Stock prices
|
1,181,084
|
-
|
-
|
-
|
-
|
1,181,084
|
|
|
13,618,940
|
1,535,430
|
-
|
-
|
-
|
15,154,370
|
|
|
|
|
|
|
|
|
49
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
|
Fair Value
|
Exposure
|
Risk
|
2020
|
2021
|
2022
|
2023
|
>2023
|
Total
|
|
|
|
|
|
|
|
|
Cost
|
|
(200,936)
|
(82,791)
|
-
|
-
|
-
|
(283,727)
|
|
Commodity
|
(441,438)
|
(94,565)
|
-
|
-
|
-
|
(536,003)
|
|
American Dollar
|
207,208
|
17,050
|
-
|
-
|
-
|
224,258
|
|
Euro
|
7,853
|
894
|
-
|
-
|
-
|
8,747
|
|
Mexican Peso
|
25,441
|
(6,170)
|
-
|
-
|
-
|
19,271
|
|
|
|
|
|
|
|
|
Fixed asset
|
|
(8,366)
|
277
|
-
|
-
|
-
|
(8,089)
|
|
American Dollar
|
(8,366)
|
277
|
-
|
-
|
-
|
(8,089)
|
|
|
|
|
|
|
|
|
Expenses
|
|
618
|
118
|
-
|
-
|
-
|
736
|
|
American Dollar
|
618
|
118
|
-
|
-
|
-
|
736
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
(516,089)
|
-
|
-
|
-
|
-
|
(516,089)
|
|
Stock prices
|
(516,089)
|
-
|
-
|
-
|
-
|
(516,089)
|
|
|
(724,773)
|
(82,396)
|
-
|
-
|
-
|
(807,169)
|
II. Credit
Risk
Concentration
of credit risk on trade receivables
A substantial
part of the Company’s sales are made to distributors, supermarkets and
retailers, within a broad distribution network. Credit risk is reduced because
of the widespread number of customers and control procedures used to monitor
risk. Historically, the Company has not experienced significant losses on
receivables from customers.
Concentration
of credit risk on counterpart
In order to
minimize the credit risk of its investments, the Company has adopted procedures
for the allocation of cash and investments, taking into consideration limits and
credit analysis of financial institutions, avoiding credit concentration, i.e.,
the credit risk is monitored and minimized to the extent that negotiations are
carried out only with a select group of highly rated counterparties.
The selection
process of financial institutions authorized to operate as the Company’s
counterparty is set forth in our Credit Risk Policy. This Credit Risk Policy
establishes maximum limits of exposure to each counterparty based on the risk
rating and on each counterparty's capitalization.
In order to
minimize the risk of credit with its counterparties on significant derivative
transactions, the Company has adopted bilateral “trigger” clauses. According to
these clauses, where the fair value of an operation exceeds a percentage of its
notional value (generally between 10% and 15%), the debtor settles the
difference in favor of the creditor.
50
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
As at March 31, 2020, the Company held its main
short-term investments with the following financial institutions: Banco do
Brasil, Bradesco, Bank Mendes Gans, BNP Paribas, Caixa Econômica Federal,
Citibank, Itaú, JP Morgan Chase, Santander, ScotiaBank and Toronto Dominion
Bank. The Company had derivative agreements with the following financial
institutions: Banco Bisa, Banco Galícia, BBVA, Barclays, BNB, BNP Paribas,
Bradesco, Citibank, Deutsche Bank, Itaú, Goldman Sachs, JP Morgan Chase,
Macquarie, Merrill Lynch, Morgan Stanley, Santander, Standard Bank, ScotiaBank
and TD Securities.
The carrying amount of cash and cash equivalents,
investment securities, trade receivables excluding prepaid expenses, recoverable
taxes and derivative financial instruments are disclosed net of provisions for
impairment and represents the maximum exposure of credit risks at March 31,
2020. There was no concentration of credit risk with any counterparties as at
March 31, 2020.
III. Liquidity Risk
Historically, Ambev’s primary sources of cash flow have
been cash flows from operating activities, the issuance of debt, bank borrowings
and equity securities. Ambev’s material cash requirements have included the
following:
·
|
Debt servicing;
|
·
|
Capital expenditures;
|
·
|
Investments in companies;
|
·
|
Increases in ownership of Ambev’s
subsidiaries or companies in which it holds equity investments;
|
·
|
Share buyback programs; and
|
·
|
Payments of dividends and interest on
shareholders’ equity.
|
The company believes that cash flows from operating
activities, available cash and cash equivalents as well as short term
investments, along with related derivatives and access to borrowing facilities,
will be sufficient to fund capital expenditures, financial instrument
liabilities and dividend payments going forward. It is the intention of the
company to continue to reduce its financial indebtedness through a combination
of strong operating cash flow generation and continued refinancing.
51
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
|
|
|
|
|
|
|
03/31/2020
|
|
Carrying
amount
|
Contractual cash
flows
|
Less than 1
year
|
1-2 years
|
2-3 years
|
3-5 years
|
More than
5
years
|
Trade and other payables
|
25,564,624
|
26,684,592
|
20,507,755
|
4,176,126
|
272,419
|
216,032
|
1,512,260
|
Secured bank loans
|
473,385
|
577,164
|
230,806
|
73,303
|
69,136
|
78,010
|
125,909
|
Unsecured bank loans
|
318,896
|
361,676
|
83,866
|
277,810
|
-
|
-
|
-
|
Debentures and Bonds
|
107,096
|
138,808
|
15,856
|
122,952
|
-
|
-
|
-
|
Unsecured other loans
|
140,087
|
291,868
|
55,390
|
49,348
|
41,557
|
13,003
|
132,570
|
Lease liabilities
|
2,433,986
|
3,070,415
|
623,410
|
871,746
|
420,370
|
588,676
|
566,213
|
|
29,038,074
|
31,124,523
|
21,517,083
|
5,571,285
|
803,482
|
895,721
|
2,336,952
|
|
|
|
|
|
|
|
03/31/2019
|
|
Carrying
amount
|
Contractual cash
flows
|
Less than 1
year
|
1-2 years
|
2-3 years
|
3-5 years
|
More than
5
years
|
Trade and other payables
|
25,589,612
|
26,899,005
|
21,591,972
|
3,332,859
|
285,989
|
221,654
|
1,466,531
|
Secured bank loans
|
461,154
|
577,821
|
197,614
|
70,292
|
70,884
|
87,941
|
151,090
|
Unsecured bank loans
|
212,668
|
214,522
|
21,149
|
190,604
|
2,769
|
-
|
-
|
Debentures and Bonds
|
106,611
|
141,712
|
15,856
|
122,467
|
-
|
3,389
|
-
|
Unsecured other loans
|
134,466
|
261,927
|
56,205
|
49,154
|
41,414
|
13,801
|
101,353
|
Lease liabilities
|
2,147,905
|
2,766,595
|
572,184
|
616,217
|
466,326
|
447,618
|
664,250
|
|
28,652,416
|
30,861,582
|
22,454,980
|
4,381,593
|
867,382
|
774,403
|
2,383,224
|
IV. Equity price
risk
Through the equity
swap transactions approved on December 20th, 2018, May
15th, 2019 and December 19th, 2019 by Ambev’s Board of
Directors (seeNote 1 - Corporate
information), the Company, or its subsidiaries, will receive the
price variation related to its shares traded on the stock exchange or ADRs,
neutralizing the possible effects of stock-price variation in view of the
share-based payment of the Company. As these derivative instruments are not
characterized as hedge accounting, they were not therefore designated to any
hedge.
At March 31,
2020, an exposure equivalent to R$0.7 billion (R$1.9 billion as of December 31,
2019) in AmBev’s shares (or ADRs) was partially hedged, resulting in a loss in
the income statement of R$541,225 (a gain in income statement of R$79,056 as of
March 31, 2019).
V. Capital
management
Ambev is
continuously optimizing its capital structure, aiming to maximize shareholder
value while keeping the desired financial flexibility to execute the strategic
projects. Besides the statutory minimum equity funding requirements that apply
to the Company’s subsidiaries in different countries, Ambev is not subject to
any externally imposed capital requirements. When analyzing its capital
structure, the Company uses the same debt ratings and capital classifications as
applied in the Company’s interim financial statements.
52
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For
the period ended March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Financial
instruments
(a) Financial
instrument categories
Management of
the financial instruments held by the Company is affected through operational
strategies and internal controls to assure liquidity, profitability and
transaction security. Financial instrument transactions are regularly reviewed
for the effectiveness of the risk exposure that Management intends to cover
(foreign exchange, interest rate, etc.).
The table
below shows all interim financial instruments recognized in the financial
statements, segregated by category:
|
03/31/2020
|
|
Fair value
through other comprehensive income
|
Amortized
cost
|
Fair value
through profit or loss
|
Total
|
Financial assets
|
|
|
|
|
Cash and cash equivalents
|
4,716,670
|
8,487,802
|
-
|
13,204,472
|
Trade receivables excluding prepaid expenses
|
-
|
5,607,067
|
-
|
5,607,067
|
Investment securities
|
-
|
200,856
|
44,823
|
245,679
|
Financial instruments derivatives
|
-
|
-
|
669
|
669
|
Derivatives hedge
|
-
|
-
|
371,080
|
371,080
|
Total
|
4,716,670
|
14,295,725
|
416,572
|
19,428,967
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Trade payables and put option granted on subsidiary
and other liabilities
|
-
|
18,234,764
|
4,241,160
|
22,475,924
|
Financial instruments derivatives
|
-
|
-
|
516,758
|
516,758
|
Derivatives hedge
|
-
|
-
|
662,160
|
662,160
|
Interest-bearning loans and
borrowings
|
-
|
3,473,450
|
-
|
3,473,450
|
Total
|
-
|
21,708,214
|
5,420,078
|
27,128,292
|
|
12/31/2019
|
|
Fair value
through other comprehensive income
|
Amortized
cost
|
Fair value
through profit or loss
|
Total
|
Financial assets
|
|
|
|
|
Cash and cash equivalents
|
3,644,665
|
8,256,001
|
-
|
11,900,666
|
Trade receivables excluding prepaid expenses
|
-
|
6,456,672
|
-
|
6,456,672
|
Investment securities
|
-
|
163,570
|
14,558
|
178,128
|
Financial instruments derivatives
|
-
|
-
|
37,534
|
37,534
|
Derivatives hedge
|
-
|
-
|
135,834
|
135,834
|
Total
|
3,644,665
|
14,876,243
|
187,926
|
18,708,834
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Trade payables and put option granted on subsidiary
and other liabilities
|
-
|
16,962,949
|
3,092,240
|
20,055,189
|
Financial instruments derivatives
|
-
|
-
|
17,904
|
17,904
|
Derivatives hedge
|
-
|
-
|
337,466
|
337,466
|
Interest-bearning loans and
borrowings
|
-
|
3,062,804
|
-
|
3,062,804
|
Total
|
-
|
20,025,753
|
3,447,610
|
23,473,363
|
|
|
|
|
|
(b)
Classification of financial instruments by type of fair value
measurement
IFRS 13
defines fair value as the price that would be received to sell an asset or be
paid to transfer a liability in an orderly transaction between market
participants at the measurement date.
53
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Also pursuant
to IFRS 13, financial instruments measured at fair value will be classified
within the following categories:
Level 1 – quoted prices (unadjusted) in active markets
for identical assets or liabilities that the entity can access at the
measurement date valuation;
Level 2 –
inputs other than quoted prices included within Level 1 that are observable for
the asset or liability, either directly or indirectly; and
Level 3 – unobservable inputs for the asset or
liability.
|
|
|
03/31/2020
|
|
12/31/2019
|
|
|
|
|
|
|
|
|
|
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Financial assets
|
|
|
|
|
|
|
|
|
|
Financial asset at fair value through other
comprehensive income
|
4,716,670
|
-
|
-
|
4,716,670
|
|
3,644,665
|
-
|
-
|
3,644,665
|
Financial asset at fair value through profit or
loss
|
44,823
|
-
|
-
|
44,823
|
|
14,558
|
-
|
-
|
14,558
|
Derivatives assets at fair value through profit or
loss
|
-
|
669
|
-
|
669
|
|
-
|
37,534
|
-
|
37,534
|
Derivatives - operational hedge
|
110,175
|
260,905
|
-
|
371,080
|
|
25,156
|
110,678
|
-
|
135,834
|
|
4,871,668
|
261,574
|
-
|
5,133,242
|
|
3,684,379
|
148,212
|
-
|
3,832,591
|
Financial liabilities
|
|
|
|
|
|
|
|
|
|
Financial liabilities at fair value through profit
and loss (i)
|
-
|
-
|
4,241,160
|
4,241,160
|
|
-
|
-
|
3,092,240
|
3,092,240
|
Derivatives liabilities at fair value through
profit or loss
|
-
|
516,758
|
-
|
516,758
|
|
-
|
17,904
|
-
|
17,904
|
Derivatives - operational hedge
|
122,669
|
539,491
|
-
|
662,160
|
|
43,209
|
294,257
|
-
|
337,466
|
|
122,669
|
1,056,249
|
4,241,160
|
5,420,078
|
|
43,209
|
312,161
|
3,092,240
|
3,447,610
|
|
|
|
|
|
|
|
|
|
|
(i) Refers to
the put option granted on subsidiary as described in Note 13 d(4).
Reconciliation of changes in the categorization of Level
3
Financial liabilities at December 31,
2019
|
3,092,240
|
Total gains and losses in
the period
|
1,148,920
|
Losses/(gains) recognized
in net income
|
91,623
|
Losses/(gains) recognized
in equity
|
1,057,297
|
Financial liabilities at March 30,
2020
|
4,241,160
|
(c) Fair value
of financial liabilities measured at amortized cost
The Company’s
liabilities, interest-bearing loans and borrowings, trade payables excluding tax
payables, are recorded at amortized cost according to the effective rate method,
plus indexation and foreign exchange gains/losses, based on closing indices for
each exercise.
The financial
instruments recorded at amortized cost are similar to the fair value and are not
material for disclosure.
54
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Calculation of
fair value of derivatives
The Company
measures derivative financial instruments by calculating their present value,
through the use of market curves that impact the instrument on the computation
dates. In the case of swaps, both the asset and the liability positions are
estimated independently and brought to present value, where the difference
between the result of the asset and liability amount generates the swaps market
value. For the traded derivative financial instruments, the fair value is
calculated according to the adjusted exchange-listed price.
Margins given
in guarantee
In order to
comply with the guarantee requirements of the derivative exchanges and/or
counterparties in certain operations with derivative financial instruments, as
at March 31, 2020 the Company held R$867,584 in highly liquid financial
investments or in cash, classified as cash and cash equivalents and investment
securities (R$816,928 on December 31, 2019).
Offsetting of
financial assets and liabilities
For financial
assets and liabilities subject to settlement agreements by the net or similar
agreements, each agreement between the Company and the counterparty allows this
type of settlement when both parties make this option. In the absence of such a
settlement, the assets and liabilities will be settled by their amounts, but
each party will have the option to settle on net, in case of default by the
counterparty.
22. COLLATERAL
AND CONTRACTUAL COMMITMENTS WITH SUPLLIERS, ADVANCES FROM CUSTOMERS AND
OTHER
|
03/31/2020
|
12/31/2019
|
|
|
|
Collateral given for the Company’s own
liabilities
|
857,692
|
817,036
|
Other commitments
|
1,464,055
|
1,245,169
|
|
2,321,747
|
2,062,205
|
|
|
|
Commitments to suppliers
|
15,294,450
|
15,877,298
|
|
15,294,450
|
15,877,298
|
The collateral
provided for liabilities totaled approximately R$2,321,747 on March 31, 2020
(R$2,062,205 on December 31, 2019), including R$696,853 (R$693,276 on December
31, 2019) of cash guarantees. The deposits in cash used as guarantees are
presented as part of other assets. To meet the guarantees required by derivative
exchanges and/or counterparties contracted in certain derivative financial
instrument transactions, Ambev maintained on March 31, 2020, R$857,584
(R$816,928 on December 31, 2019) in highly liquid financial investments or in
cash, classified as
55
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
cash and cash equivalents and investment securities (Note 21 – Financial instruments and risks).
Most of the balance relates to commitments with suppliers of packaging.
Future contractual commitments on March 31, 2020 and December 31, 2019 were as follows:
|
03/31/2020
|
12/31/2019
|
|
|
|
Less than 1 year
|
6,533,869
|
9,300,551
|
Between 1 and 2 years
|
4,983,739
|
3,861,872
|
More than 2 years
|
3,776,842
|
2,714,875
|
|
15,294,450
|
15,877,298
|
23. CONTINGENT LIABILITY
The Company has contingent liabilities related to lawsuits arising from its normal course of business. Due to their nature, such legal proceedings involve certain uncertainties including, but not limited to, court and tribunals rulings, negotiations between affected parties and governmental actions, and consequently the Company’s Management cannot estimate the likely timing of resolution of these matters at this stage.
Contingent liabilities with a probable outcome are fully recorded as liabilities (Note 12 – Provisions).
The Company has lawsuits related to tax, civil and labor matters for which the likelihood of loss is classified as possible by Management, and for which there are no provisions, as the composition and estimates of amounts as follows:
|
03/31/2020
|
12/31/2019
|
|
|
|
Income tax and social contribution
|
45,817,788
|
43,453,049
|
Value-added and excise taxes
|
23,053,857
|
22,226,320
|
PIS and COFINS
|
2,945,650
|
3,066,849
|
Labor
|
346,025
|
353,296
|
Civil
|
380,507
|
388,732
|
Others
|
1,035,274
|
1,036,024
|
|
73,579,101
|
70,524,270
|
Principal lawsuits with a likelihood of possible loss:
Except for monetary inflation and the cases described below, there was no relevant changes in the main cases with possible chances of loss when compared to the period ending on December 31, 2019.
56
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Brazilian Federal Taxes
Goodwill CND Holdings
In
November 2017, Ambev received a tax assessment related to the goodwill
amortization resulting from the merger of CND Holdings into Ambev. The decision
from the first-level administrative court was unfavorable to Ambev. Ambev filed
an appeal to the Lower Administrative Court. In February 2020, Ambev received a
partially favorable decision at the Lower Administrative Court. Ambev is
awaiting the issuance of the decision in order to file the applicable
appeals.
The updated amount related to this uncertain tax position
as at 31 March 2020 was approximately R$1.0 billion (R$1.1 billion as of
December 31, 2019). Ambev has not recorded any provisions for this matter as is
classified as possible losses.
Disallowance of taxes paid abroad
Since 2014, Ambev has been receiving tax assessments from
the Brazilian Federal Tax Authorities related to the disallowance of deductions
associated with alleged unproven taxes paid abroad by its subsidiaries and has
been filing defenses. The cases are being challenged at the administrative
level. In November 2019, the Lower Administrative Court rendered a favorable
decision to Ambev regarding the assessment from 2010 in the amount of
approximately R$0.2 billion, which became definitive. In January 2020, regarding
four of these assessments (from 2015 and 2016), in the amount of approximately
R$3.6 billion, the Lower Administrative Court rendered unfavorable decisions.
Ambev is awaiting formal notification of the decision to file the applicable
appeals. The other cases are still waiting final decisions.
The updated amount related to this uncertain tax position
as at 31 March 2020 was approximately R$10.2 billion
(R$10.1 billion as of December 31, 2019). Ambev has not recorded any provisions for this matter as
is classified as possible losses.
Margin Profit
In
January 2020, Arosuco, a subsidiary of the Company, received a tax assessment
from the Federal Revenue Service of Brazil regarding the disallowance of the
income tax reduction benefit provided for in Provisional Measure No. 2199-14 /
2001. In this context, an administrative challenge was presented within the
legal term and the judgment will be awaited by the Regional Judgment Office of
the Federal Revenue Service of Brazil.
The updated amount related to this uncertain tax position
as at 31 March 2020 was approximately R$2.0 billion. Ambev has not recorded any
provisions for this matter as
57
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
it is classified as possible losses.
ICMS and IPI
ICMS-ST Trigger
Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev has been above the fixed price table basis established by the relevant States; in such cases the State tax authorities have understood that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels of the courts.
Ambev management estimates the amount related to this issue as at 31 March 2020 was approximately R$8.1 billion (R$7.7 billion as at 31 December 2019), classified as a possible loss and, therefore, for which Ambev has made no provision. Ambev recorded provisions in the total amount of R$8.3 million (R$8.3 million as at December 31, 2019) in relation to certain proceedings for which it considers the chances of loss to be probable due to specific procedural issues.
Manaus Free Trade Zone – IPI and PIS/COFINS
In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/or zero rated from IPI excise tax and social contributions. With respect to IPI, Ambev’s subsidiaries have been registering IPI excise tax presumed credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving several tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.
Ambev has also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) amounts allegedly due under social contribution over Arosuco’s remittance.
In April 2019, the Federal Supreme Court (“STF”) announced its judgment on Extraordinary Appeal No. 592,891/SP, with binding effects, deciding on the rights of taxpayers registering presumed IPI excise tax credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF.
58
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
The cases are being challenged at both the administrative
and judicial levels. Ambev management estimates the possible losses in relation
to these assessments to be R$4.6 billion (R$4.2 billion at December 31, 2019) as
at 31 March 2020. Ambev has not recorded any provision in connection with these
assessments.
Contingent assets
In
accordance with IAS 37 - Provisions, Contingent Liabilities and Contingent
Assets, the contingent assets are not recognized in consolidated financial
statements, except when realization of income is virtually certain.
The Company and its subsidiaries are demanding the refund
of the PIS and COFINS paid including the ICMS and/or ICMS-ST in their taxable
basis for the period from 1990 onwards. Considering the different taxation
systems applicable to the cold drinks sector, as well as due to corporate
reorganizations that have occurred over the years, the Company and its
subsidiaries have several lawsuits claiming such refunds. For the period until
2009, as well as for the period in which the special regime for cold drinks was
in place – i.e. from January 2009 to April 2015 (article 58-J of Law 10,833, of
2003, also known as REFRI) – the amounts involved in the refund requests are
still being calculated. For the period after the termination of the special
regime for cold drinks (currently in place), the Company estimates that the
contingent asset related to the matter is R$1.9 billion.
In
September 2019, the Company obtained a final favorable decision and recognized
the right from Companhia Antarctica Paulista (incorporated by Ambev S.A.) to
exclude the ICMS from the COFINS taxable base in the period from March 2000 to
May 2005, reason why it recognizing a recoverable tax of approximately R$0.6
billion.
59
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
24.
NON-CASH ITEMS
|
03/31/2020
|
12/31/2019
|
Cash financing cost other than
interests
|
-
|
(2,027)
|
Fair value of option granted on a
subsidiary
|
(2,133)
|
(36,033)
|
Effect of application of IAS 29
(hyperinflation)
|
(102,432)
|
45,621
|
Acquisition of investments payables
|
34,431
|
20,000
|
25.
RELATED PARTIES
Policies and
practices regarding the realization of transactions with related
parties
The Company
adopts corporate governance practices recommended and/or required by the
applicable law.
Under the
Company’s by-laws, the Board of Directors is responsible for approving any
transaction or agreements between the Company and/or any of its subsidiaries
(except those fully subsidiaries), directors and/or shareholders (including
shareholders, direct or indirect shareholders of the Company). The Antitrust
Compliance and Related Parties Committee of the Company is required to advise
the Board of Directors of the Company in matters related to transactions with
related parties.
Management is
prohibited from interfering in any transaction in which conflict exists, even in
theory, with the Company’s interests. It is also not permitted to interfere in
decisions of any other Management member, requiring documentation in the minutes
of meeting of the Board any decision to abstain from the specific
deliberation.
The Company’s
guidelines with related parties follow reasonable or commutative terms, similar
to those prevailing in the market or under which the Company would contract
similar transactions with third parties. These are clearly disclosed in the
financial statements as formalized in written contracts.
Transactions
with Management members:
In addition to
short-term benefits (primarily salaries), the Management members are entitled to
participate in the Stock Option Plan and Share-Based Plan (Note 20 –
Share-based payments).
60
AMBEV
S.A.
Notes to the interim consolidated
financial statements
For the period ended
March 31, 2020
All amounts in
thousand of Brazilian Reais unless otherwise stated
Total expenses
related to the Company’s Management members were as follows:
|
03/31/2020
|
03/31/2019
|
|
|
|
Short-term benefits (i)
|
5,791
|
5,739
|
Share-based payments (ii)
|
9,810
|
9,519
|
Total key Management remuneration
|
15,601
|
15,258
|
(i) These
correspond substantially to Management’s salaries and profit sharing (including
performance bonuses).
(ii) These
correspond to the compensation cost of stock options and restricted stocks
granted to Management. These amounts exclude remuneration paid to members of the
Fiscal Council.
Excluding the
above-mentioned plan (Note 20 – Share-based
payments), the Company no longer has any type of transaction with
the Management members or pending balances receivable or payable in its balance
sheet.
Transactions
with the Company's shareholders:
a) Medical,
dental and other benefits
The Fundação
Antonio e Helena Zerrenner Instituição Nacional de Beneficiência (“Fundação
Zerrenner) is one of Ambev’s shareholders, and at September 30, 2019 held 10.2%
of its total share capital. Fundação Zerrenner is also an independent legal
entity whose main goal is to provide Ambev’s employees, both active and retired,
with health care and dental assistance, technical and superior education
courses, facilities for assisting elderly people, through direct initiatives or
through financial assistance agreements with other entities. On March 31, 2020
and December 31, 2019, actuarial responsibilities related to the benefits
provided directly by Fundação Zerrenner were fully funded by plan assets, held
for that purpose, which significantly exceeded the liabilities at those dates.
Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the
amounts of economic benefit available to the Company, arising from
reimbursements or reductions of future contributions.
The expenses
incurred by Fundação Zerrenner in providing these benefits totaled R$62,153
(R$69,114 on March 31, 2019), of which R$54,857 and R$7,296 related to active
employees and retirees respectively (R$60,993 and R$8,121 on March 31, 2019
related to active employees and retirees respectively).
b) Leasing
Ambev, through
its subsidiary BSA (labeling), has an asset leasing agreement with Fundação
Zerrenner, for R$22,439 maturing on December 31, 2022.
c) Leasing –
Ambev head office
Ambev has a
leasing agreement of two commercial sets with Fundação Zerrenner, which is being
re-negotiated.
61
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
d) Licensing agreement
The Company maintains a licensing agreement with Anheuser-Busch, Inc., to produce, bottle, sell and distribute Budweiser products in Brazil, Canada and Argentina, and sale and distribution agreements for Budweiser products in Guatemala, in Dominican Republic, in Paraguay, in El Salvador, in Nicaragua, in Uruguay, in Chile, in Panama, in Costa Rica and in Puerto Rico. In addition, the Company produces and distributes Stella Artois products under license to ABI in Brazil and Canada and, by means of a license granted to ABI, it also distributes Brahma’s product in the United States and several countries such as the United Kingdom, Spain, Sweden, Finland and Greece. The amount recorded was R$382 (R$408 at March 31, 2019) and R$109,355 (R$92,088 at December 31, 2019) as licensing income and expense, respectively.
Ambev has licensing agreements with the Group Modelo, subsidiaries of ABI, for to import, promote and sell products Corona (Corona Extra, Corona Light, Coronita, Pacifico and Negra Modelo) in the countries of the Latin America and Canada.
Transactions with related parties
|
|
|
|
03/31/2020
|
Current
|
Trade receivables (i)
|
Other Trade receivables (i)
|
Trade payables (i)
|
Other Trade payables (i)
|
AB Africa
|
7,651
|
-
|
-
|
-
|
AB InBev
|
15,399
|
-
|
(70,880)
|
-
|
AB Package
|
4,301
|
-
|
(163,718)
|
-
|
AB Services
|
8,632
|
-
|
(1,611)
|
-
|
AB USA
|
56,443
|
5,773
|
(257,543)
|
-
|
Cervecería Modelo
|
9,426
|
-
|
(345,030)
|
-
|
Cervecerías Peruanas
|
2,651
|
-
|
(23,372)
|
-
|
Inbev
|
519
|
83,933
|
(58,780)
|
-
|
ITW International
|
-
|
-
|
(288,566)
|
(150,213)
|
Panama Holding
|
35,490
|
-
|
(73)
|
-
|
Others
|
10,515
|
1,048
|
(47,246)
|
-
|
|
151,027
|
90,754
|
(1,256,819)
|
(150,213)
|
(i) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.
|
|
|
|
|
Current
|
Trade receivables (i)
|
Other Trade receivables (i)
|
Trade payables (i)
|
Other Trade payables (i)
|
AB InBev
|
24,847
|
-
|
(46,678)
|
-
|
AB Procurement
|
1,081
|
-
|
(176)
|
-
|
AB Services
|
15,537
|
-
|
(2,002)
|
-
|
AB USA
|
38,756
|
4,504
|
(180,908)
|
-
|
Bavaria
|
607
|
-
|
(63,968)
|
-
|
Cervecería Modelo
|
16,059
|
-
|
(223,141)
|
-
|
Inbev
|
687
|
64,519
|
(23,866)
|
-
|
ITW International
|
-
|
-
|
(223,733)
|
(108,895)
|
Panama Holding
|
27,238
|
166
|
(173)
|
-
|
Others
|
18,736
|
803
|
(126,072)
|
(41)
|
|
143,548
|
69,992
|
(890,717)
|
(108,936)
|
(i) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.
62
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
The tables below represent the transactions with related parties recognized in the income statement:
|
|
03/31/2020
|
Company
|
Sales and others
|
Service fees / Reimbursement of expenses and others
|
|
Product Purchases and Others
|
Service Fee / Expense Reimbursement and Others
|
Net Finance Cost
|
AB InBev
|
68
|
-
|
|
(25,236)
|
-
|
6
|
AB Package
|
-
|
-
|
|
(23,718)
|
-
|
-
|
AB USA
|
5,420
|
-
|
|
(284,719)
|
(660)
|
-
|
Cervecería Modelo
|
-
|
-
|
|
(301,194)
|
-
|
-
|
Cervecerías Peruanas
|
-
|
-
|
|
(8,852)
|
-
|
-
|
GCC India
|
-
|
-
|
|
-
|
(1,368)
|
-
|
Inbev
|
-
|
-
|
|
(32,795)
|
-
|
-
|
ITW International
|
-
|
-
|
|
-
|
-
|
(8,614)
|
Oriental Brewery
|
2,542
|
-
|
|
-
|
-
|
-
|
Others
|
162
|
38
|
|
(6,988)
|
-
|
-
|
|
8,192
|
38
|
|
(683,502)
|
(2,028)
|
(8,608)
|
|
|
03/31/2019
|
Company
|
Sales and others
|
Service fees / Reimbursement of expenses and others
|
|
Product Purchases and Others
|
Service Fee / Expense Reimbursement and Others
|
Net Finance Cost
|
AB USA
|
7,986
|
11
|
|
(186,892)
|
(571)
|
-
|
AB Package
|
-
|
-
|
|
(15,466)
|
-
|
-
|
Cervecería Modelo
|
115
|
-
|
|
(295,562)
|
-
|
-
|
Inbev
|
-
|
-
|
|
(23,422)
|
-
|
-
|
Others
|
236
|
49
|
|
(43,587)
|
(8,691)
|
(21,684)
|
|
8,337
|
60
|
|
(564,929)
|
(9,262)
|
(21,684)
|
Denomination used in the tables above:
AB InBev Procurement GmbH (“AB Procurement”)
|
Anheuser-Busch Inbev Africa (Pty) Ltd. (“AB Africa”)
|
Anheuser-Busch InBev N.V. (“AB InBev”)
|
Anheuser-Busch Inbev Services LLC (“AB Services”)
|
Anheuser-Busch Inbev USA LLC (“AB USA”)
|
Anheuser-Busch Packaging Group Inc. (“AB Package”)
|
Bavaria S.A. (“Bavaria”)
|
Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)
|
Cerveceria Nacional S de RL (“Panamá Holding”)
|
GCC Services India Private Ltd. (“GCC India”)
|
Inbev Belgium N.V. (“Inbev”)
|
Interbrew International B.V. (“ITW International”)
|
Oriental Brewery Co. Ltd. (“Oriental Brewery”)
|
Unión de Cervecerias Peruanas Backus Y Johnston S.A.A. (“Cervecerias Peruanas”)
|
63
AMBEV S.A.
Notes to the interim consolidated financial statements
For the period ended March 31, 2020
All amounts in thousand of Brazilian Reais unless otherwise stated
26. EVENTS AFTER THE REPORTING PERIOD
In April 2020 Ambev approved new loans for working capital financing. These include the issuance of promissory notes and bank credit notes (CCB), among other types of loans, for a total amount of R$ 1,450 million. On May 6, 2020, with the approval of another loan for 200 million Canadian dollars (approximately R$ 796 million), the total borrowed amount reached to approximately R$ 2,246 million.
64
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 15, 2020
|
|
|
|
AMBEV S.A.
|
|
|
|
|
By:
|
/s/ Lucas Machado Lira
|
|
Lucas Machado Lira
Chief Financial and Investor Relations Officer
|
Ambev (NYSE:ABEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ambev (NYSE:ABEV)
Historical Stock Chart
From Apr 2023 to Apr 2024